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Abstract 
The global microfluidics market was valued at USD 4.75 billion in 2018 and it is estimated to be 
valued at USD 27.90 billion in 2023 [1]. One of the important factors, propelling the growth of the 
market is the rising demand for Point-of-Care (POC) testing. Microfluidic devices are key in 
fulfilling this demand due to their portability, small volume of sample requirement, and 
microfabrication techniques that simplify the industrialization. POC testing not only allows 
healthcare experts to determine a diagnosis at a patient’s bedside, but also empowers non-expert 
users to observe their health status. One of the most important samples that are used for these 
microfluidic devices is blood, due to the presence of various biomarkers in it. However, the 
existence of millions of cells in the blood introduces a great level of noise for the detection the 
particular biomarkers, therefore, blood plasma separation is the first step for POC blood testing 
devices. 
In this thesis, the design, development, and validation of a POC platform that integrates a novel 
blood plasma separator (BPS) design to multiple readouts systems is the main goal. To achieve 
this, firstly, the hypothesis that air bubbles trapped in dead-end zones of a passive BPS can be used 
to enhance the extraction of plasma from whole blood is validated numerically by the 
Computational Fluid Mechanics (CFD) and experimentally. According to the results, the proposed 
design that produces enough quantity and quality of plasma is introduced for the first time in novel 
forward and reverse ABO/Rh blood grouping POC.  
In some other practical situations, there is a need to separate the cellular components from the 
blood continuously. Therefore, the hypothesis that cross-flow filtration could be applied to 
separate plasma from blood continuously was investigated. Compared to recent works in the 
literature [2-7] the proposed device’s contribution is  capable to optimize either purity or yield of 
the extracted plasma by calibrating the suitable flow rate depending on the demand of the 
separation. One of the applications where these characteristics are desirable is in bleeding or 
thrombotic disorders. Currently, the stressful lifestyle and the aging of the population have led to 
an increase in such disorders [8,9]. The possibility of having a portable system to evaluate the 
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global hemostasis of a patient is of great interest to reduce the burden on the public health systems. 
The proposed BPS was coupled to an interchangeable biomimetic surface to study effects of the 
new oral anticoagulant Apixaban (APIX) and compare the results to previous conventional 
techniques. The test showed an excellent agreement with the conventional techniques, while the 
amount of the required sample and reagent have been reduced.  
The prototypes of all the proposed devices were initially fabricated using soft-lithography and wet-
etching processes. The scalability of these processes is complex and nowadays machining process 
based on femtoseconds laser pulses is an interesting candidate for the scalability of the production. 
Hence, the hypothesis that a novel production method based on direct laser microfabrication 
method using a femtosecond laser was proven capable to machine the sub-micron channels 
required for the production of successful BPS. The promising results proved that this method 
provides a fast manufacturing approach useful for various applications such as POC devices. 
Keywords: Separation science, Microfluidics, Lab-on-a-Chip, Point-of-Care, Microfabrication, Blood typing, 
Hemostasis, high-throughput separation, Capillary separation. 
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Overall objectives 
 
The general goal of this thesis was to design and develop microfluidic BPS that could contribute 
to the construction of future lab-on-a-chip (LOC) systems, especially for POC applications. 
Microfluidics is the science of controlling and manipulating fluids, usually in microliters range, 
inside the microchannels. This technology has started in the early 1990s and has grown 
exponentially [10]. It is observed that microfluidics is an essential tool for life science research or 
from a larger point of view in biotechnologies. 
Based on the aforementioned hypothesis the more specific goals were: 
1. To validate that air bubbles trapped in dead-end zones of a passive BPS can be used to 
enhance the extraction of plasma from whole blood providing a higher yield.  
2. To design and fabricate a portable ABO/Rh blood typing test that performs both direct and 
indirect methods simultaneously from a single blood droplet by integrating the optimized 
BPS with the required biomarkers. 
3. To validate the possibility of utilizing the cross-flow filtration for continuous plasma 
extraction from the blood by optimizing the BPS dimensions and geometric design, 
numerically and experimentally. 
4. To design and fabricate a hemostasis-on-a-chip platform to evaluate hemostasis disorders 
near the patients by combining the BPS and impedance spectroscopy techniques. 
5. To define a manufacturing methodology that uses infrared (IR) ultrashort pulse direct laser 
also known as femtoseconds laser microfabrication method to batch manufacture the 
aforementioned designs. 
The various studies included in the thesis deal with the need of a microfluidic BPS that can be 
integrated with multiple parameters readouts to make POC systems Figure 1 shows a current 
integration of the BPS with a lateral flow test strip, which is currently in process of 
commercialization.  
 
  
 
10 Microfluidic Platform for Multiple Parameters Readouts in a Point-of-Care 
  
Figure 1. Schematic picture of the microfluidic BPS design in progress to be in the market. 
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Introduction 
Human blood 
Blood is the most important body fluid in clinical diagnosis and it is also one of the simplest ways 
to determine the internal performance of the human body studying its cellular components, such 
as red blood cells (RBC), white blood cells (WBC), platelets and the rest of the biomarkers 
suspended in the plasma (Figure 2a). Researchers have characterized the rheological behavior of 
blood, estimating a density of 1060 𝑘𝑘𝑘𝑘/𝑚𝑚3 and a viscosity of 0.02 𝑃𝑃𝑃𝑃. 𝑠𝑠[11]. 
RBCs occupies around 44% volume in the blood, typically shaped as biconcave discs (Figure 2b) 
approximately 6 to 8 µm in diameter and a thickness at the thickest point of 2 to 2.5 µm and a 
minimum thickness in the center of 0.8 to 1 µm. Being very elastic and much smaller than most of 
the other human cells, under high shear flows the shape of the red blood cells can deform reducing 
its smaller dimension even to less than 1µm. WBCs are approximately 1% of blood volume and 
are spherical cells with approximately 8.5 µm in diameter and they defend the body against 
infection. Platelets make up a blood volume of approximately 0.7% and are responsible for blood 
clotting in the case of an open wound. Platelets have a discoidal shape; they are approximately 2 
to 4µm in diameter and 1 µm in thickness and are much stiffer than RBCs. These blood cells are 
suspended in the liquid phase of blood (Plasma), which is straw-yellow in color and occupies 
approximately 54% volume in the blood. Plasma is essentially an aqueous solution with various 
circulating biomarkers such as antibodies, hormones, nutrients, the end-products of cellular 
metabolism, clotting factors, immunoglobulins and an abundance of proteins [12,13]. 
Biomarkers indicate the presence of certain diseases in an individual, therefore, plasma is the base 
of a wide range of assays and is needed at clinical chemistry testing for prognosis and clinical 
diagnosis of diseases [14]. Existence of the blood cells in plasma may provide a great level of 
noise in the biochemical determinations and reduces or interferes the precision of different sensing 
technologies during the analysis, therefore, cell separation from plasma is one of the most basic, 
essential steps in disease diagnostics field and it is a major challenge since more than 5 million 
cells have to be separated from one microliter of blood [15]. 
  
 
12 Microfluidic Platform for Multiple Parameters Readouts in a Point-of-Care 
 
Filtration 
There are definitely different situations where separation is a key step.  For instance, clinical 
analysis, diagnosis, and preparation techniques rely heavily on separation at some stage of the 
process. Since many biologically relevant samples such as whole blood, saliva, and cell lysates are 
highly complex and because the targets for detection can be present in extremely low 
concentrations, separation is often an essential part of any analytical process. In lab environments, 
centrifugation is generally accepted as the most conventional method. Although the process of 
centrifugation is easy and widely employed, it limits its usage to a laboratory. Therefore, some of 
the drawbacks associated to this process are the large volume of sample requirement, the increased 
number of manipulation errors, its bulkiness, the required time to process the sample and in some 
cases it may result in rupture of blood cells due to the centrifugal force [16]. 
The needs for miniaturization 
Employing microfluidic devices have been considered as an effective manner to overcome many 
of the aforementioned limitations, providing the same effectiveness with smaller volume 
Figure 2. a) The schematic pictures of the blood components, b) Three-dimensional cross-section of a single RBC with its 
dimensions. 
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requirement of the blood sample. The introduction of microfabricated BPS allowed preanalytical 
standardization, cost-effectiveness, rapid measurements, portability, protection against 
contamination and evaporation, the advantage of working with the laminar flow which allows 
controlled mixing, and decreased reagent consumption. Besides, the microfluidic blood/plasma 
separation methods have the advantage of connecting directly to microsensors and creating 
miniaturized diagnostic devices. 
The aforementioned advantages, not only empower the chronic patient having a portable 
diagnostic tool to monitor their health status, but also can help the undeveloped countries, to have 
access to the best medical diagnostic technologies. Microfluidic systems allow miniaturization and 
integration of complex functions, which could move sophisticated diagnostic tools out of the 
developed-world laboratories. These systems must be inexpensive, accurate, reliable, rugged and 
well suited to the medical and social contexts of the developing world [17]. 
In recent years, considerable progress is made in the development of microfabricated systems for 
its use in the chemical and biological sciences. The development has been driven by a need to 
perform rapid measurements on a small volume of sample. However, at a more primary level, 
interest in miniaturized analytical systems has been stimulated by the fact that physical processes 
can be more easily controlled and harnessed when instrumental dimensions are reduced to the 
micrometer scale. Such systems define new operational paradigms and provide predictions about 
how molecular synthesis which might be revolutionized in the fields of high-throughput synthesis 
and chemical production [18]. 
POC testing devices 
As it is mentioned previously, the overall objective of this research is developing a stand-alone 
POC device which can implement different types of tests without the need for sample pretreatment 
to diagnose the patient’s disease with high efficiency at a reasonable time (minutes at most). The 
goal for many researchers in the fields of microfluidics and LOC is the development of devices 
that will be able to diagnose a patient on the spot, wherever the patient happens to be, in just a few 
minutes without the need for extensive laboratory testing. 
POC diagnostics or bedside tests are medical tools or devices that can diagnose disease in a 
patient’s community, outside of a hospital setting. They include both low-tech and high-tech. The 
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driving notion behind a point-of-care-test (POCT) is to bring the test conveniently and immediately 
to the patient. This increases the likelihood that the patient, physician, and care team will receive 
the results quicker, which allows for immediate clinical management decisions to be made. 
In recent years the use of POCT has been spread and some biomarkers are commonly being 
determined by POCT devices such as blood glucose testing, rapid coagulation testing (PT/INR), 
rapid cardiac markers diagnostics (TRIAGE), drugs of abuse screening, urine strips testing, 
pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics 
(HemoCue), infectious disease testing and cholesterol screening glucose, blood gas 
analysis/electrolytes, activated clotting time for high dose heparin monitoring, and rapid strep [19].  
Miniaturized blood plasma separation technique has been thriving from 2006. Most POC systems 
need microscale blood plasma separation [20]. Plasma from blood has to be extracted in order to 
proceed with most tests. A variety of solutions has appeared recently to miniaturize blood plasma 
separation, which has currently been performed in three main formats [21]: 
1. The CD format is based on a radial geometry and exploiting the laser CD developments 
(Figure 3a). The CD-based format allows neat sample preparation as well as analysis, and 
therefore, are good examples of LOC devices in terms of functional integration. An 
excellent exhaustive review of the subject [22,23] showed that the plasma extraction in a 
CD-based format relies on the centrifugal force forcing the heavy cellular content towards 
the external edge of the CD, while the plasma is siphoned out by various valving systems. 
The success of the plasma separation in CD format relies on these valving systems, which 
have included passive siphoning, [24] hydrophobic, capillary, [25,26] or ferrowax 
microvalves [2827,28]. Protocols on the CD-based format are rapid, and the fabrication of 
CD cartridges is simple and cost-effective. Parallelization is enabled by having several 
similar chambers within one CD cartridge. However, the technology is limited by the use 
of numerous valves and the fact that the movement of fluid from one chamber to another 
relies only on the centrifugation speed [22]. 
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2. The paper format is based on capillary flow migration on a cost-effective and 
biodegradable resource (Figure 3b). From 2009 paper-based microfluidics has been the 
center of a flurry of research activities [29,30]. Paper has been widely used for lateral-flow 
assays, such as glucose and lipid measurements [31], coagulation measurements [32] or 
pregnancy tests. But more recently, the paper has been re-engineered to host a variety of 
integrated microfluidic functions, including plasma extraction from blood. Paper is used in 
several devices to extract plasma from blood, few examples showcase paper as the only 
supporting format for the entire assay. While paper can be used conveniently to separate 
several microliters of blood such as finger-prick volumes, it rapidly clogs and is unsuitable 
for larger volumes, limiting its use to the analysis of highly concentrated analytes, such as 
glucose [33] or abundant proteins [34]. However, its low volume of extracted plasma, 
limits the variety of the applications and it is expected that researchers in the paper field 
will come up with several analysis techniques compatible with low plasma volume, which 
might translate into a range of useful commercial lateral flow diagnostic kits. 
3. The microfluidic chip format is featuring fluid flowing through microchannels and based 
on classical microfabrication techniques (Figure 3c). Practically, the procedure of blood 
plasma separation in microfluidic devices can be performed using either passive or active 
mechanisms. Passive methods work autonomously taking advantage of sedimentation [35-
42], microfiltration [43-53], and cell deviation [54-69] while active microfluidic methods 
rely on external energy sources such as acoustic separation [70-74], electrical forces [75-
77], and magnetic separation [78-83]. While paper format only works for passive 
applications and CD formats only for active applications, microfluidic chip formats can be 
versatile. This format of blood/plasma separation can be portable, low cost and integrated 
with continuous-flow separation processes as well. In this thesis, a BPS microfluidic design 
will be analyzed and optimized to separate by passive and active methods. 
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Figure 3. Three different filtration formats. a) CD format, b) Paper format, and c) Microfluidic chip format.  
   Shadi Karimi 
 
17 Doctoral thesis 
Methods 
Passive  
Passive separation methods refer to those that not using external forces relay on the channel 
geometry and the capacity of the particles/cells to diffuse, intrinsic hydrodynamic forces, such as 
punch flow fraction, deterministic lateral displacement, inertial forces and intrinsic physical 
property of the cells such as sedimentation to induce plasma extraction from cell components. In 
these separation methods, particles are sorted exclusively by their mechanical properties, such as 
size, shape, and deformability, using only the geometries of microchannels, the flow itself, and 
inherent hydrodynamic forces. 
Blood plasma separation from undiluted blood without the help of external forces is essential to 
create a POC device. Most of these passive techniques suffered from clogging problems and low 
yield [84,85]. This issue limits the amount of plasma available for analysis and consequently the 
type of test that can be implemented using microchip filtration. Therefore, the main challenge in 
the passive method is postponing the clogging process and achieving a higher yield. 
Active  
Active separation refers to the defined manipulation of the working fluid by active components 
such as micropumps, microvalves or other external forces such as electric, acoustic or magnetic. 
Continuous-flow separation using microfluidics devices enables the separation of a fluid by an 
external imposed flow rate generate by micro-pump through microchannels that deviates particles 
trajectory through hydrodynamics. However, their low-throughput or low separation efficiency is 
preventing the adoption of this technology for continuous-flow separation [2,3,5,86,87]. 
Continuous-flow processes are used in a wide range of applications such as bioanalytical, 
chemical, energy and environmental fields [88]. 
The physics of blood flow 
Blood is a complex, and multicomponent fluid; therefore, the modeling and analytical prediction 
of its flow behavior is a challenge. Blood flow in the body is generally considered as laminar flow 
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and from a physical point of view, can be defined as a non-Newtonian, and shear-thinning fluid 
due to its cellular suspension. 
The margination of particles in blood has applications in microfluidic devices for the removal of 
pathogens and also for the separation of cells. It is, therefore, vital to understand the mechanisms 
that are responsible for margination. For margination to occur, the particles need to escape the 
fluid-flow streamlines and move laterally as a result of gravity, buoyancy, hydrodynamic forces, 
van der Waals forces, and/or Brownian motion. The trend is resulted from the competition between 
the adhesion to the walls and drag forces. At low shear rates, the adhesion forces are larger than 
the drag forces, regardless of the particle orientation. At higher shear rates, these forces depend on 
the orientation of the particle [89]. 
The forces exerted on a cell in a microfluidic channel are lift force, drag force induced by lateral 
fluid flow, buoyant force, and gravitational force which are shown in Figure 4. The net force acting 
on a cell can be expressed as: 
?⃗?𝐹𝑛𝑛𝑛𝑛𝑛𝑛 =  ?⃗?𝐹𝐿𝐿 + ?⃗?𝐹𝐷𝐷 + ?⃗?𝐹𝐵𝐵 + ?⃗?𝐹𝑔𝑔 1 
Where ?⃗?𝐹𝐿𝐿 is the lift force in 𝑌𝑌 direction (width of the channel), ?⃗?𝐹𝐷𝐷 is the drag force in 𝑋𝑋 direction 
(length of the channel), ?⃗?𝐹𝐵𝐵 is the buoyant force in 𝑍𝑍 direction (height of the channel) and ?⃗?𝐹𝑔𝑔 is the 
gravitational force in 𝑍𝑍 direction (height of the channel). Gravity facilitates the migration of the 
larger particles (500 nm to 10 μm) in the direction of the gravitational force. 
In a microfluidic channel, because the Reynolds number is typically low, the drag force also known 
as Stokes’s drag can be expressed as follows: 
𝐹𝐹𝐷𝐷 = −6𝜋𝜋𝜋𝜋𝜋𝜋(𝑣𝑣𝑚𝑚 − 𝑣𝑣𝑝𝑝) 2 
where 𝜋𝜋 is the radius of the particle, 𝜋𝜋 is the viscosity of the medium, 𝑣𝑣𝑚𝑚 is the velocity of the 
flow, and 𝑣𝑣𝑝𝑝 is the velocity of the particle. The buoyant force acting on a spherical particle 
suspended in a medium can be expressed as follows: 
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𝐹𝐹𝐵𝐵 = 4 3� 𝜋𝜋𝜋𝜋3𝜌𝜌𝑚𝑚𝑘𝑘 3 
where 𝜌𝜌𝑚𝑚 is the density of the medium, and 𝑘𝑘 is the acceleration due to gravity. The gravitational 
force acting on a spherical particle is expressed as follows: 
𝐹𝐹𝑔𝑔 = 4 3� 𝜋𝜋𝜋𝜋3𝜌𝜌𝑃𝑃𝑘𝑘 4 
Where 𝜌𝜌𝑃𝑃 is the density of the particle. The gravitational and buoyant forces only act in the vertical 
direction on the cell, whereas the drag force acts in the lateral direction. In human blood, the 
density of the plasma (1.025 𝑘𝑘/𝑚𝑚𝑚𝑚) is smaller than that of the RBCs (1.097 𝑘𝑘/𝑚𝑚𝑚𝑚), WBCs (1.073 
𝑘𝑘/𝑚𝑚𝑚𝑚), and platelets (1.045 𝑘𝑘/𝑚𝑚𝑚𝑚). Thus, all the blood cells sink as they follow the flow in the 
microfluidic channel [87]. 
The lift force leads to migration across the streamlines. In the expansion structure of the 
microchannel where the streamline changes direction smoothly, a particle is primarily subjected 
to the shear-gradient lift force (?⃗?𝐹𝐿𝐿𝑠𝑠). As it is shown in Figure 4, it is arising from the curvature of 
the Hagen-Poiseuille flow that acts downward and parallel to the velocity gradient and drives the 
particle towards the channel walls. On the other hand, the wall-effect lift force (?⃗?𝐹𝐿𝐿𝑤𝑤), that acts 
upward and parallel to the velocity gradient, pushes the particle away from the wall toward the 
channel centerline; the net force of these two forces is the lift force (?⃗?𝐹𝐿𝐿)  that is responsible for 
particle migration away from the wall. 
This lift force can be calculated by: 
𝐹𝐹𝐿𝐿  =  𝜋𝜋?̇?𝛾  𝑟𝑟3ℎ 𝑓𝑓(1 − 𝑣𝑣) 5 
Where ?̇?𝛾 is the shear rate, r is the radius of the particle, h is the particle’s distance from the wall 
and 𝑓𝑓(1 − 𝑣𝑣) is a dimensionless function based on the reduced particle volume and is given by: 
𝑉𝑉 = 𝑣𝑣43𝜋𝜋( 𝑆𝑆4𝜋𝜋)3 2�  6 
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where Ѵ is the enclosed volume and S is the surface area of the particle [89]. 
Generally, the discoidal shape of RBCs, combined with their elasticity and membrane fluidity, 
results in strong lift forces that push RBCs toward the center of the channel and lead to the 
formation of a CFL. 
The microfluidic channels with large aspect ratio cross-sections are largely influenced by channel 
geometry, particle size, and flow properties changes. The CFL thickness varies with the channel 
diameter and its geometry. The CFL layer is thicker for higher flow rates, since the lift force pushes 
particles stronger away from the walls [92]. 
The principle of design 
The proposed BPS design is taking advantage of several aspects including hydrodynamics, and 
blood rheology in order to maximize the volume of extracted plasma. As it is depicted in Figure 
5a, this design contains two parts: the top part which has three separated microchannels; one main 
Figure 4. The schematic of side view of the micro channel. The forces exerted on the 
cells in a microchannel. 𝑭𝑭𝑳𝑳𝒔𝒔 is the shear gradiant lift force and 𝑭𝑭𝑳𝑳𝒘𝒘 is the wall induced 
lift force and  𝑭𝑭𝑳𝑳 is the net lift force, 𝑭𝑭𝑫𝑫 is the drag force, 𝑭𝑭𝑩𝑩 is the buoyant force and 
𝑭𝑭𝒈𝒈 is the gravitational force. 
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channel for the passage of blood and two side channels also known as plasma collector channels 
which are responsible to collect the plasma flowing from the sides of the channel due to the axial 
migration effect of the red blood cells across the main channel. This part is fabricated using the 
conventional soft-lithography technique on a single layer of polydimethylsiloxane (PDMS). The 
bottom part is a tank placed below these microchannels for plasma collection, which is fabricated 
via the wet-etching method on a glass substrate. This tank contains an array of pillars to hold the 
weight of the PDMS and create a capillary pump that fosters the plasma separation. The plasma in 
the tank will be collected by capillary force via two plasma collector channels as it is illustrated in 
Figure 5b. The pillars are chosen to be in a diamond shape, since they have minimum fluidic 
resistance compared to other shapes such as circle, elongated, pine and rectangular [90]. The depth 
of the tank is selected to be below 1.8µm which is less than the minimum size of RBCs, therefore, 
Figure 5.  a) Schematic picture of the complete BPS device, b) The cross-section view of the BPS device.  
a) 
b) 
PDMS 
Etched glass 
Plasma collector channels 
Main channel 
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blood cells cannot penetrate from the main channel to the plasma collector channels and 100% 
pure plasma could be extracted from the whole blood. 
The initial design of the main channel [90] as it showed in Figure 5 was a simple straight channel. 
This previous passive design obtained a yield of 2% from the whole blood and to increase the yield 
the active separation techniques such as dielectrophoretic forces were helped to separate 10% 
plasma from diluted blood (1:1). Therefore, in this work, the goal was to improve the yield for 
both passive and active methods from undiluted blood. The results from the previous designs are 
tabulated in Table 1. The yield and purity of the extracted plasma were calculated by these 
equations: 
 
 
 
 
 
Yield = �output sample volumeinput sample volume � ∗ 100 7 
Purity = �1 − � final cells densityinitial cells density�� ∗ 100 8 
According to Fåhræus–Lindqvist effect [91] the viscosity of the blood, changes with the diameter 
of the tube it travels through. For the tubes with the diameters between 10 to 300 µm, the cells will 
travel in centerline and near the main channel’s wall a layer free of cells will form known as cell-
free-layer (CFL) which facilitate the extraction of plasma. Therefore, a longer perimeter of the 
main channel´s walls should lead to the release of more plasma. On the other hand, the appearance 
of a dead-end zone due to hydrodynamics [76] showed that the length of the branches longer than 
400 μm highlights RBCs can be captures on these areas slightly diminishing the number of 
Table 1. The comparison of the previous designs based on the yield and purity of the extracted plasma. 
 Method Design Dilution ratio Yield Purity 
Madadi et al. [46,90] Passive Straight No 2% 98% 
Mohammadi et al. 76] Active Corrugated 1:1 10% 99% 
Mohammadi et al. [77] Active Straight 1:1 10% >99% 
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circulating RBCs. Therefore, in order to take advantage of these effects, the design proposed by 
Madadi et al. was modified to design 2 as it is depicted in Figure 6. This design has the particularity 
that at the end of each corrugated channel initially a bubble of air is created and shortly after 
disappeared due to the PDMS permeability to gasses.  The vanishing time of these bubbles is 
longer than the time required to fill the channel by capillarity, therefore this process acted as an 
additional pump enhancing the possibility to extract more plasma from the initial droplet. Design 
number 3 has a larger zone at the end of each branch as it is shown in Figure 6, to enhance the size 
of the bubble to pull the cells to the side and postpone the clogging process in the main channel. 
After successfully separating a higher volume of plasma from the whole blood due to the trapping 
cells in the corrugated channels, compared to the previous devices, design number 4 was proposed. 
This design has the inclined branches in which the results from CFD simulation showed that it 
facilitates the RBCs to travel to the sides compared to the perpendicular branches. All of the 
aforementioned designs were symmetrical and the main channel’s width was increased while 
approaching each of the branches. The CFD models showed that the cells slowed down at the entry 
of the branches as a result of an increased cross-section of the main channel. Therefore, design 
number 5 with an asymmetrical characteristic enhanced its predecessors due to an increased 
velocity of the flow at the main channel compared to the symmetrical designs. By adding an 
expansion-contraction to this design, as it is illustrated in Figure 6, design 6 was proof to provide 
the highest yield among the other designs. These constrictions that are created in the main channel, 
generated a local flow acceleration and delayed the RBCs clogging of the filtration area. The 
optimized design could postpone the clogging process by the aid of bubble-based lopsided 
channels, and an expansion-contraction geometry which consequently maximized the volume of 
the extracted plasma. Therefore, the design for the passive BPS is selected and the second 
parameter which is the impact of the height of the main channel is studied numerically and 
experimentally. The results showed that the shorter height leads to extract more plasma. For this 
reason, the height of 15 µm is fixed for the proposed design. This passive BPS approached 12% 
yield with 100% purity in approximately 10 minutes. Therefore, an adequate amount of plasma 
which is needed to perform the ABO/Rh test, is achieved which is explained in detail in Article I. 
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For the active applications by imposing a flow rate, the cells still follow the flow lines due to the 
channel dimensions (small value of Reynolds number) so that the flow is in the complete laminar 
zone. Therefore, the cells could not escape to the branches and with flow rates in the range of 1 to 
10  𝑚𝑚𝑚𝑚 ℎ� the larger zones at the end of the branches stayed empty. Figure 7 shows the flow path 
of the corrugated channel for high-throughput applications. The experimental setup of the active 
BPS is illustrated in Figure 7a, and the real device with the connectors are depicted in Figure 7b. 
There is a blood inlet which is connected to the syringe pump, one blood outlet, and one plasma 
outlet which are collected in separate syringes. Figure 7c is the velocity streamline of the 3D 
simulated BPS in the corrugated channel. The best design for the active method from the numerical 
results is the one without pillars, which is impossible in practice to deal with due to the flexibility 
of PDMS that will collapse the channel. Therefore, the idea of replacing the PDMS with another 
Figure 6.  Design development; 1) simple channel, 2) corrugated channel, 3) corrugated channel with the larger 
zone at the end, 4) lopsided channel, 5) asymmetric lopsided channel, and 6) Final design. 
   Shadi Karimi 
 
25 Doctoral thesis 
material which can be rigid, hydrophilic and be fabricated below 2µm is proposed. In Article III 
the details of the fabrication method are expressed. 
 
  
Figure 7. a) The experimental setup of the high-throughput BPS, b) The real BPS device, c) The  3-D simulated 
design of the corrugated channel.  
a) b) 
c) 
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Applications 
Blood typing test  
The blood typing test is obligatory in any pregnancy, transfusion, and organ transplant. 
Transfusion of non-compatible blood groups results in severe health problems that can be a serious, 
potentially fatal. Currently, more than thirty genetic-based blood typing methods are known [92]. 
Although, the ABO system [93] and the Rh system [94] are the most important ones in transfusion. 
This method was discovered by Karl Landsteiner in 1901. First, he patterned four major groups; 
A, B, AB, and O. The ABO blood group system denotes the presence of either A or B antigens on 
their RBC which indicate blood group A or B respectively, or a combination of A and B that is 
blood group AB or neither which is group O. The presence of antigen A on RBC means the absence 
of corresponding IgM antibodies in the serum. For instance, blood group A, always have antigen 
A on their RBCs and antibodies B in their serum. Rhesus (Rh) factor is an inherited protein found 
on the RBCs. If the blood has this protein, the group is Rh-positive, and the lack of this protein 
indicates the blood group as an Rh-negative. The mismatch of antigen and antibodies combination 
results in agglutination. Agglutinated blood cells can be detected from several sensitive and 
reliable assays such as the tube test, traditional slide test, the gel column agglutination, the 
microplate method, and the affinity column technology. These assays need special laboratory tools 
operated by trained laboratory staff, which increases the relative costs [95] and manipulation 
errors. Some of the modern technologies in ABO/Rh blood typing are synthetic/natural receptors, 
paper-based, molecular blood typing [96-99], emerging strategies, and blood test kits [95]. 
However, the conventional methods of blood typing are still considered the most reliable tests 
which are the most adopted in clinical laboratories [100]. In an emergency diagnosis situation, the 
lateral flow assays based on a functionalized cellulose membrane are more common but less 
accurate. Recently the Micronics ABO/Rh-Card provided a rapid, credit card-sized test for the 
simultaneous determination of an individual’s ABO/Rh blood type from a finger prick sample of 
whole blood in 2 minutes [101]. A recent study of 26 fatal accidents due to the incompatibility of 
ABO/Rh showed that in 24% of the cases pre-transfusion bedside compatibility test (PBCT) was 
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not done at the patient bedside, in 32% the PBCT was not done at all, and in 44% it was done on 
the transfused unit and not to the patient. Human mistakes related to blood typing are cited as the 
most frequent cause of problems in transfusion. Another study of two commercial POCT showed 
that the error occurred in 30% of the assays. The errors were attributed to the poor technique of 
the operator, device failure or incorrect interpretation [102]. In order to decrease these errors, 
operating another method on the same sample to validate and enhance the accuracy of the primary 
results is needed. The direct (forward) method is based on a possible reaction of the antigens 
around the patients’ RBCs with known antibodies while the indirect (reverse) method utilizes the 
reaction of natural antibodies from their plasma with identified RBCs. The comparison of the 
results from performing these two methods near the patient would significantly decrease the 
possible errors in blood typing. In other words, the indirect method is used to confirm results 
obtained in the direct method and in some countries, it is mandatory to perform both tests prior to 
a transfusion. To perform the indirect method the plasma needs to be extracted from blood. To this 
end, in order to have a POC blood grouping device, a BPS needs to divide a blood sample into five 
branches; three RBC outlets to test the direct method, and two plasma outlets for the indirect 
method. The combination of the microfluidic BPS, and the appropriate biomarkers to generate 
agglutination and visually detect the blood group leads to a stand-alone microchip which is capable 
of determining the blood grouping from both direct and indirect methods simultaneously (Figure 
8) from a single droplet of blood. 
The method of ABO/Rh blood typing in this device is based on the detection of agglutination on 
antigens of RBCs (direct method) and antibodies of plasma (indirect method). The differences 
between agglutinated and non-agglutinated samples are distinguishable by the naked eye as it is 
Figure 8. The schematic view of the proposed idea of the combination of both direct and indirect 
methods on a single cartridge. 
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shown in Figure 9 but also validated with particle analysis on the microscopic pictures. The results 
in this figure indicate the blood group A-positive since the mixture of antibody-A and antibody-D 
with the blood sample is positive. The positive reaction between RBC-B and the extracted plasma 
confirms this result. Additionally, the results of the passive BPS in ABO/Rh blood typing verified 
the quality and quantity of the extracted plasma in practical applications. This concept achieves 
fast, efficient, accurate, low cost and simple measurement of agglutination inside a passive 
microchip for both direct and indirect blood typing simultaneously. 
Hemostasis level test 
Hemostasis is a process to prevent bleeding in case of vascular injury, in fact, it happens when 
blood is presented outside of the body or blood vessels. It is the initial stage of wound healing and 
stops the body from loss of blood. This involves coagulation, blood changing from a liquid to a 
gel. During hemostasis three steps occur in a rapid sequence [103]. Vascular spasm is the first 
response as the blood vessels constrict to allow less blood to be lost. In the second step, platelet 
plug formation, platelets stick together to form a temporary seal to cover the break in the vessel 
Figure 9. The schematic picture of the expected device and the real device. The reactions between 
antibodies and antigens results in agglutinations are visible by the naked eye. 
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wall. The last step is called coagulation or blood clotting. Coagulation reinforces the platelet plug 
with fibrin threads that act as a molecular glue. Platelets are a large factor in the hemostatic process. 
They allow for the creation of the platelet plug that forms almost directly after a blood vessel has 
been ruptured. Within seconds of a blood vessel's epithelial wall being disrupted platelets begin to 
adhere to the sub-endothelium surface. It takes approximately sixty seconds until the first fibrin 
strands begin to intersperse among the wound. After several minutes the platelet plug is completely 
formed by fibrin. But if this process is deregulated or in other words thrombosis, it can because of 
cardiovascular diseases and can be life-threatening [104]. Thrombosis is the formation of a blood 
clot, known as a thrombus, within a blood vessel. It prevents blood from flowing normally through 
the circulatory system. The impact of thrombosis is increased by aging and an unhealthy lifestyle, 
therefore, providing a platform that leads to a better understanding of the hemostasis mechanism 
is needed. In order to evaluate the hemostasis process, the interaction of fibrin and platelets in 
blood clotting should be assessed which requires a combination of routine and specialized tests. 
Evaluation of hemorrhage (the opposite of hemostasis) also requires sophisticated equipment to 
identify the altered functional pathway and it is a time-consuming test. Analyzing the existence 
and function of the activators and inhibitors involving in the coagulation mechanism implies the 
thrombosis disorders diagnosis [105].    
To improve the knowledge of the hemostasis process, microfluidics can help to mimic the blood 
vessels and ex vivo coagulation [106-108]. Currently, the limit of hemostasis evaluation is carrying 
out under static conditions, for instance on the plasma sample or enriched platelets suspensions 
[109]. These tests provide a fragmented view of the hemostasis, neglecting the interactions inside 
the blood vessels. Studies employing parallel chamber technologies and perfusion annular with 
circulating blood flow have provided remarkably to the knowledge on the function of the platelets 
in the thrombotic complications under shear conditions and the hemostatic mechanism [110,111]. 
Lately, the developed microfluidic systems have facilitated the implementation of perfusion assays 
compare to the classic approaches by using a smaller volume of blood samples and simplifying 
the evaluation of the results [106-108, 112]. Therefore, the study of blood flow biorheology is of 
great interest for a better understanding of hemostasis and the effects of antithrombotic drugs [97, 
113]. Nowadays, microfluidic technologies and micro biomimetic flow chambers can provide a 
platform to study the concept of flow in blood coagulation and fibrin formation for the ex vivo 
situations [114-116]. Due to the employing of the direct oral anticoagulants (DOACs) to 
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circumvent the frequent monitoring and the dose adjustment with the classic Vitamin K antagonists 
(VKAs), there is a need to measure the effect of anticoagulant of the drugs in several situations 
such as bleeding or hospitalized or critically ill patients. Doubtfulness about the consumption of 
DOACs in patients requires an urgent invasive manner, uncertainty of overdose and recurrence of 
thrombotic events or the confirmation of adherence needs to be addressed [117,118]. Evaluation 
of the anticoagulant therapies is simple for VKAs, while it is very complex for the DOACs. 
Monitoring antiplatelet therapy or assessing the potential risk of bleeding or thrombosis requires 
specialized equipment and a definition of cutoff values for each drug. Unfortunately, the tests to 
determine the effects of DOACs on coagulation are drug-specific and are not regularly available 
in clinical laboratories. Within the help of the POC devices, the evaluation of the anticoagulant, 
the identification of a specific group of patients and the guidance of the reversal agents in case of 
overdose could be facilitated. Additionally, for the patients who are at the risk of cardiovascular 
complications, antiplatelet agents are prescribed, while monitoring their responses to these drugs 
is not demonstrated [119]. There are subgroups of patients in whom different laboratory tests 
indicate suboptimal responses to antiplatelet drugs. This condition, primarily, describes as 
resistance to the antiplatelet agent, has evolved to a more detailed concept of the patients with high 
on-treatment platelet reactivity (HPR) [120]. HPR exposes patients to an enhance of major adverse 
cardiovascular events risk and might require dual therapy. Conversely, the concept of low on-
treatment platelet reactivity (LPR) defines subgroups of patients exposed to an increased risk of 
bleeding. The balance of efficacy vs. safety in subgroups of patients will be improved by the 
optimization of antiplatelet therapy based on a reliable functional assay. To develop a POC device 
that could evaluate the contribution of the platelets and coagulation elements of hemostasis in 
minutes of blood samples at patients’ bedsides, the combination of both techniques is desired. In 
Article II, a fundamental contribution to a better understanding of the hemostasis process inside 
the vessels is presented to enhance the treatment of cardiovascular diseases. As a first step, 
designing a tool to characterize the behavior of plasma poor in platelets (PPP) and plasma rich in 
platelets (PRP) is required to create a reliable POC device for monitoring the antithrombotic 
treatment. During the last few years, DOACs were proposed to circumvent the frequent monitoring 
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of classical ones and decreased the burden on public health systems in countries where the growth 
of the elderly population has enhanced cardiovascular disease impact. But there is a need to 
measure the effectiveness of these treatments, especially at the patient’s bedside. The use of 
biomimetic microfluidic channels for studying the hemostasis process reduces the time and the 
volume of required samples and provides a platform to analyze the results at the patient’s bedside. 
In Article II, a novel microflow chamber as it is shown in Figure 10b, integrated to a replaceable 
biomimetic surface (Figure 10c) for evaluation of the hemostasis level is proposed. These two 
parts were assembled with the help of the 3D printed cascade which is illustrated in Figure 10a. 
This device requires a small amount of blood sample and reagents to perform the test in a 
reasonable time. The experimental set up of this system is shown in Figure 10d. A study about the 
APIX is done and compared with the previous conventional methods in order to validate the 
performance of this device. The results showed an excellent agreement while the volume of 
required samples was reduced. An interdigitated printed electrode is embedded in the chamber to 
measure the impedance during the coagulation procedure. This study could characterize the 
behavior of the PPP from PRP according to impedance measurement for the very first time.  
Figure 10. a) The 3D printed device assemble with the microflow chamber and biomimetic surface, b) 
The microflow chamber that is engraved on the PDMS and two connectors for inlet and outlet, c) The 
microelectrode integrated on the glass substrate,  and d)The experimental setup of the measuring the 
hemostasis level of the PPP and PRP. 
a) 
b) 
c) 
d) 
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Fabrication 
 
Nowadays with the advancement in microfluidics technology, a reliable, fast and cost-effective 
fabrication method is required to be able to compete with the conventional methods. Specifically, 
due to the complexity of the manufacturing process at the sub-micron range, most of them require 
a lithographic step which is time-consuming. Two of the main challenges facing low aspect ratio 
channels are proper bonding and avoidance of stiction. PDMS which is one of the most used 
materials in microfluidic systems due to its transparency, flexibility, and compatibility with 
biological applications, has a drawback of simply getting collapsed. PDMS can be processed with 
the soft-lithography method. This method is cost-effective and accurate but time-consuming. The 
schematic of the soft-lithography process to make a mold is illustrated in Figure 11. A glass 
substrate is the other candidate for biocompatible applications but the hose connections cannot be 
integrated easily. Besides, the wet-etching process that is schematically depicted in Figure 12 on 
the glass is time-consuming and has a huge environmental impact due to the extremely aggressive 
chemicals that are used to carve the channel. Therefore, it is difficult to be industrialized. Rapid 
prototyping in microfluidics enables prompt verifications in the experimental stage and avoids the 
Figure 11. a) A clean and dry glass is used as a substrate, b) SU-8 is spun on to the glass to achieve the desired thickness, 
c) The sketch on the SU-8 is polymerized under the UV exposure, d) The polymerized glass is washed with SU-8 developer, 
and e) The created mold is baked. 
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need for simulations that are not 100% accurate. Therefore, there is a need for rapid and cost-
effective manufacturing method especially in the sub-micron range that must be extremely reliable. 
Article III introduced a direct laser microfabrication method that is capable of manufacturing sub-
micron channels with a very low aspect ratio. This method uses an ultrashort pulse laser. In order 
to study the precision of this method, two parallel rectangles as shown in Figure 13 with different 
depth range (0.5 µm to 2 µm) and different width range (15 to 30 µm) are manufactured. 
Interferometric microscopy (S lynx Compact 3D Surface Profiler, SENSOFAR company in Spain) 
is used to measure the roughness of each pattern. Additionally, to evaluate the influence of the 
ultrashort pulse laser on the wettability of the glass, the static contact angle at each depth was 
measured (OCA 15EC, DataPhysics Instruments, Germany). Finally, the applicability of the 
manufactured sub-micron channel is validated by using it as a BPS device. 
For a femtosecond laser, the laser-material interaction time is very short. Thus, heat energy has no 
time to diffuse in a lattice. The irradiated zone of the material quickly reaches the vaporization 
temperature and the ablated particles evaporate from the surface [121]. The results showed that the 
width of the channel does not have an influence on the surface roughness, while a higher depth, 
increased the roughness. The surface roughness for the depth of 0.5 µm was not uniform and some 
peaks appeared as it is shown in Figure 13. This is due to the number of laser passes. The first laser 
pass scratched the surface and the second laser pass unified the surface, this is why for all the depth 
Figure 12. a) A clean and dry glass is used as a substrate, b) S1818 is spun on to the glass to achieve the desired 
thickness, c) The sketch on the S1818 is polymerized under the UV exposure, d) The exposed glass is washed by S1818 
developer, and e) The glass is soaked in acid to achieve the desired depth inside the glass. 
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that laser pass is an odd number (the case of 1-µm, 1.5-µm, and 2-µm-depth template) the 
roughness presents a maximum and at even number (the case of 0.75-µm, 1.25-µm, 1.75-µm depth 
template) the roughness improves. Additionally, the results showed increasing the depth, 
decreased the standard deviation. The measurement of the static contact angles on the patterns, 
irritated at laser passes of 2, 3, 4, 5, 6, and 7, denoted a dependency of the surface wettability on 
the laser passes, higher laser passes decreased the surface wettability but it revealed the hydrophilic 
behavior for all laser passes, which made it suitable for performing a self-driven test. 
The open-top sub-micron channel with an array of pillars was manufactured using this process and 
the watertight property was reached by a PDMS cover to create the BPS. The plasma extracted 
with 100% purity and during the bonding process and operating the device there was no problem 
of collapsing due to the texture on the surface of the glass, which avoided stiction. This method 
had other advantages compared to current sub-micron watertight manufacturing methods. It was a 
faster manufacturing method for channel dimensions greater than 750 nm in-depth (about 40 
seconds for a rectangle with the area of 18.5*12.5 mm2). 
Figure 13. The schematic picture of the engraved glass by femtosecond laser and 
the microscopic view of the real glass. 
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Figure 14.  a) The microscopic picture of the surface with 0.5µm depth, patterned with one laser pass, b) the 
microscopic picture of the surface with 0.75µm depth patterned with two laser passes. 
a) b) 
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Conclusion 
 
This thesis presents a series of improvements on a cross-flow filtration design for blood plasma 
separation. The main design has been modified to operate properly in both capillary and imposed 
flow conditions. In both cases, the appropriate performance has been accredited in practical 
applications: ABO/Rh blood typing and Hemostasis-on-Chip. 
The hypothesis of enhancing the yield by keeping the 100% purity of the extracted plasma is 
validated by inducing the formation of air bubbles in the dead-end zones of the channels. A novel 
microfluidic channel with dead-end branches at each side was designed numerically using CFD 
modeling. The lopsided design with expansion-contraction geometry achieved a better RBC 
trapping in the branches. The presence of the dead-end zone at the end of each branch confined an 
air bubble that was disappearing during the process of separation. This modification not only 
increased the perimeter of the main channel to extract more plasma but also elongated the 
separation time by delaying the clogging process caused by the accumulation of RBCs in the main 
channel. The proposed design requires only a single droplet (50μl) of the whole blood without the 
need for any external forces or pre-analytical steps and a volume of 6-μl of plasma could be 
extracted in about 10 minutes with the highest purity level (100%). The microfluidic device was 
closed except for the inlet and outlet ports, protecting the reaction from environmental interference. 
The volume of the extracted plasma and its impressive purity can be successfully used for various 
diagnostic applications. 
The proposed passive portable BPS is designed to perform the ABO/Rh blood typing from both 
direct and indirect methods. This chip operates with only blood a droplet while decreasing the 
processing time and manipulation errors. The detection of the blood typing is based on the 
agglutination which is visible by naked eyes and validated by microscopic pictures. Different 
blood types at different hematocrit ratios were analyzed using the proposed device. For hematocrit 
levels lower than 50% the results showed a good agreement in all four types of blood. This chip is 
more accurate than the chips in the market since it works with both direct and indirect methods 
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and the results from the indirect method are for validating the results from the direct method. This 
fact decreases manipulation errors. 
Several modifications in the separation tank and the main channel were investigated to enhance 
the yield and purity for the high-throughput purpose. A 3-D CFD numerical simulation was 
performed to characterize the optimal design which provides a better separation at different flow 
rates. The numerical results are consistent with the experimental characterization of the device, 
which showed that the active BPS device has a better yield at a higher flow rate but lower purity. 
This is due to the flexibility of the PDMS that at the high shear rate it stretches and leads to the 
leakage of blood cells from the main channel. In contrast previous works, this has the potential to 
reach a yield as high as 19% with an acceptable purity of 77%. This BPS device not only worked 
with undiluted blood but also is reusable.  
In Article II, a microchip has proposed that diagnoses the coagulation disorders with the help of 
impedance spectroscopy in a biomimetic approach. This device is microfabricated in the form of 
a microflow chamber with a replaceable biomimetic surface. The biomimetic surface embedded 
printed interdigitated gold electrodes to characterize the fibrinogen formation or platelets 
aggregation by reducing the requirement samples and testing time. The results showed a 
distinguishable behavior of PPP versus PRP. The change in PPP behavior was more noticeable at 
high frequencies while PRP showed a remarkable change at both low and high frequencies. This 
study is a base for the capability of POC devices for measuring the effect of anticoagulant on 
platelet aggregation or fibrinogen formation. 
The previous findings are of direct practical application. The main current limitation is the 
existence of a batch fabrication method capable to produce the proposed geometries. In Article III, 
a novel rapid technique to manufacture a watertight sub-micron channel using femtosecond laser 
results in a successful definition of sub-micron channels from 500 nm and above. The width of the 
channel has higher accuracy for lower depth. For a channel with 1-µm-depth, the deviation in 
width was 0.4% while the accuracy regarding the depth increased with higher depth. This 
methodology has the potential to batch manufacture sub-micron channels essential in BPS devices. 
The technique was successfully used to extract plasma from blood with 100% purity. The findings 
suggest that this method has several advantages compared to current sub-micron watertight 
manufacturing methods. It takes about 40 seconds to create a rectangle with an area of 18.5*12.5 
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mm2 while the mentioned conventional methods usually take several hours. Moreover, the intrinsic 
texture of the surface that is created while machining avoids collapse or obstruction of the small 
channels due to the deflection of the top layer. Based on the results, the number of laser passes has 
a significant influence on the aforementioned texture. The odd number of laser pass increased the 
surface roughness while the next laser pass decreased it. The number of laser passes had an impact 
on the contact angles: as the laser passes increased, the surface wettability decreased. Laser focus 
spot size limited the reduction of the width of the sub-micron channel. The glass maintained 
transparent which enables the colorimetric and particle counts analysis systems. From the outcome 
of this investigation, it is possible to conclude that the femtosecond laser is suitable for the batch 
fabrication of microfluidic BPS. 
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Future works 
 
Current findings suggest that the approach of cross-flow filtration and hydrodynamic separation 
can be useful for plasma extraction and its application to different diagnostic purposes. Aside from 
the already shown applications in ABO/Rh blood grouping and hemostasis studies, the BPS has 
the potential to miniaturize enzyme-linked immunosorbent assay (µELISA) and other current 
diagnostic techniques. The addition of a mixer to the BPS would enhance could provide portability 
to ELISA in conventional diagnostic tool in medicine but also in plant pathology, and 
biotechnology, as well as a quality control check in various industries. Many of the applications 
requires the extracted plasma or fluid to be mixed with specific regents. Therefore, designing a 
mixer compatible with the separation times and the volumes provides is required.   
The results from the proposed device suggest that this approach could also be useful for isolation 
of other cells by their size. For instance, the circulating tumor cells (CTC) from cerebrospinal fluid 
(CSF), Mycobacterium tuberculosis bacteria (MTB) from saliva or and parasites from blood. 
CTCs in CSF are very rare but if present it is a clear sign for the diagnosis of certain illnesses.  
CSF volume in adults ranges from 125 mL to 150mL [112] and its collection process is not very 
pleasant. Therefore, finding a way to decrease the sample requirement for CTC detection is 
desired. For this matter, the same strategy of our BPS design to sort cancer tumor cells is suggested. 
The CSF can pass through the channel and only CTCs which are bigger in size will be trapped in 
the main channel. Besides, the septation of CTCs from whole blood which are also very rare in 
numbers compared to millions of blood cells in blood, is a challenge due to the need to process in 
continuous an important volume of sample to only detect few cells. But this capability could 
provide for the first time a CTC detection device for POC testing. One idea is to lyse the RBCs 
and sort the WBCs and CTCs by their size to isolate the CTCs. 
The other application is tuberculosis detection, which the biggest challenge is in the prompt 
diagnosis of TB. By redesigning the BPS device for capturing the MTB from saliva, a platform for 
detecting and trapping these bacteria could be prepared. This method should be sensitive, rapid, 
and is expected to find use in resource-limited settings where TB is still the one of the most 
prevalent illness. 
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Parasites can be present in very low numbers, sometimes lower than 1 per μl blood compared to 
the millions of red blood cells in the same volume [122]. The problems are the same for other types 
of rare cells. In addition, clinical analysis of acute viral infection in blood requires the separation 
of viral particles from blood cells, since the aforementioned microfluidic device can use to 
continuously purify blood from viral particles like HIV particles.  
Doubtlessly in the near future, significant advances in POCT due to the emerging technologies, 
will reduce the health-care costs and lead to improve diagnostics systems. These advances will 
empower patients and the general population by providing them with personalized devices 
equipped with tools for preventive medicine, mobile health care, and telemedicine [123]. 
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A passive portable microfluidic blood–plasma 
separator for simultaneous determination of direct 
and indirect ABO/Rh blood typing 
Shadi Karimi,   Pouya Mehrdel,   Josep Farré-Lladós and Jasmina Casals-Terré  * 
 
The blood typing test is mandatory in any transfusion, organ transplant, and pregnancy situation. There is 
a lack of point-of-care (POC) blood typing that could perform both direct and indirect methods using a 
sin- gle droplet of whole blood. This study presents a new methodology combining a passive 
microfluidic blood–plasma separator (BPS) and a blood typing detector for the very first time, leading to 
a stand-alone microchip which is capable of determining the blood group from both direct and indirect 
methods simul- taneously. The proposed design separates blood cells from plasma by applying 
hydrodynamic forces im- posed on them, which overcomes the clogging issue and consequently 
maximizes the volume of the extracted plasma. An axial migration effect across the main channel is 
responsible for collecting the plasma in plasma collector channels. The BPS novel design approached 
12% yield of plasma with 100% purity in approximately 10 minutes. The portable BPS was designed and 
fabricated to perform ABO/Rh blood tests based on the detection of agglutination in both antigens of 
RBCs (direct) and antibodies of plasma (indi- rect). The differences between agglutinated and non-
agglutinated samples were distinguishable by the na- ked eye and also validated by particle analysis of 
microscopic pictures. The results of this passive BPS in ABO/Rh blood grouping verified the quality and 
quantity of the extracted plasma in practical applications 
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Abstract: In the case of vascular injury, a complex process (of clotting) starts, involving mainly
platelets and coagulation factors. This process in healthy humans is known as hemostasis, but when
it is deregulated (thrombosis), it can be the cause of important cardiovascular diseases. Nowadays,
the aging of the population and unhealthy lifestyles increase the impact of thrombosis, and therefore
there is a need for tools to provide a better understanding of the hemostasis mechanisms, as well as
more cost-effective diagnosis and control devices. This study proposes a novel microflow chamber,
with interchangeable biomimetic surfaces to evaluate global hemostasis, using reduced amounts
of blood sample and reagents, and also a minimized time required to do the test. To validate the
performance of this novel device, a study on the new oral anticoagulant Apixaban (APIX) has been
performed and compared to previous conventional techniques. The test shows an excellent agreement,
while the amount of the required sample has been reduced (only 100 µL is used), and the amount of
reagent as well. An imprinted electrode embedded in the chamber in order to measure the impedance
during the coagulation process. This approach distinguishes the impedance behavior of plasma poor
in platelets (PPP) and plasma rich in platelets (PRP) for the first time.
Keywords: organ-on-a-chip; vein-on-a-chip; impedance; microfluidics; hemostasis
1. Introduction
Hemostasis is the result of the collaboration between plasma and blood cells to stop bleeding
during the initial steps of wound healing. Current unhealthy habits and aging of the population alter
the physiologic balance of blood coagulation, resulting in thrombotic complications. During thrombosis,
the aggregation of platelets and coagulation products can prevent blood flow and cause damage in
downstream organs, resulting in ischemia and/or tissue death.
Evaluation of hemostasis requires a combination of routine and specialized tests to assess the
interaction of platelet and fibrin components involved in blood clotting. Evaluation of hemorrhagic
disorders does also require time-consuming tests and sophisticated equipment to identify the altered
functional pathways. The diagnosis of thrombotic disorders implies the analysis of the presence and
function of activators and inhibitors participating in these coagulation mechanisms.
Nowadays, the evaluation of hemostasis is performed under static conditions. The introduction
of microfluidics approaches provides the possibility to mimic blood flow and ex vivo coagulation
with minute volume samples, therefore it is already being used as an important tool to improve the
knowledge on hemostasis processes [1–3].
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A common limitation of the majority of current tests applied to the evaluation of hemostasis is that
they are performed under static conditions, on samples of plasma or enriched platelet suspensions [4].
In contrast with these static tests, bleeding or thrombotic complications occur in whole blood flowing
through damaged vessels. Thus, current tests applied to the evaluation of hemostasis provide a
fragmented view of the isolated components of the hemostasis, disregarding the interactions that must
necessarily occur in flowing blood. Studies using perfusion annular and parallel chamber technologies
with circulating blood have contributed significantly to the knowledge on the function of platelets in the
hemostatic mechanism and the thrombotic complications under shear conditions [5,6]. More recently
developed microfluidic devices have facilitated the implementation of perfusion assays in a more
simplified way than the classic approaches, using small blood samples and facilitating the evaluation
of the results [1–3,7].
Therefore, the study of blood flow biorheology is of great interest for a better understanding of
hemostasis and the effects of antithrombotic drugs [8,9]. Now microfluidics and micro biomimetic flow
chambers can provide platforms for the ex vivo study of the effects of flow upon blood coagulation
and fibrin formation [10–12].
Due to the introduction of direct oral anticoagulants (DOACs) to circumvent the frequent
monitoring and dose adjustment with classic Vitamin K antagonists (VKAs), there is now a need
for methods to measure the anticoagulant effects of these drugs in several situations: Hospitalized
or critically ill or bleeding patients. Uncertainties about the use of DOACs in patients requiring an
urgent invasive procedure, suspicion of overdose, recurrence of thrombotic events or confirmation
of adherence, need to be addressed [13,14]. Assessment of the impact of anticoagulant therapies is
simple for VKAs, but very complex for the DOACs. Monitoring antiplatelet therapy or assessing
the potential risk of bleeding or thrombosis requires specialized equipment, specific devices and a
definition of cut-off values for each drug. Unfortunately, tests used to assess the effects of DOACs
on coagulation are drug-specific, and not routinely available at clinical labs. Availability of reliable
point of care (POC) tests which require less volume of sample and a short turnaround of results would
facilitate the evaluation of the anticoagulant activity, the identification of specific patient groups and
the guidance of reversal agents in case of overdose.
Moreover, antiplatelet agents are prescribed and administered at fixed doses to patients at
risk of cardiovascular complications. Although regular monitoring of their actions is not advised,
several studies have demonstrated that responses to antiplatelet drugs are not uniform [15]. There are
subgroups of patients in whom different laboratory tests indicate suboptimal responses to antiplatelet
drugs. This condition, initially defined as “resistance” to the antiplatelet agent, has evolved to a more
descriptive concept of patients with “high on-treatment platelet reactivity” (HPR) [16]. HPR exposes
patients to an increased risk of major adverse cardiovascular events, and may require dual therapy.
Conversely, the concept “low on-treatment platelet reactivity” (LPR) defines subgroups of patients
exposed to an enhanced bleeding risk. Optimized antiplatelet therapy based upon a reliable functional
assay will improve the balance of efficacy vs. safety in subgroups of patients.
The combination of techniques evaluating the platelet and coagulation elements of hemostasis is
the initial step towards the development of POC devices that could efficiently and reliably evaluate
the contribution of both components in minute blood samples or at patients’ bedsides, which is
highly desirable.
The research work presented here leads to a fundamental contribution to the understanding of
hemostasis processes inside vessels, which is of utmost importance to the medical community in order
to enhance the treatment of cardiovascular diseases. The design and the validation of the microflow
chamber as a tool to characterize a dominant behavior of plasma poor in platelets (PPP) or plasma rich
in platelets (PRP) is the base for a highly reliable point-of-care device for antithrombotic treatment
monitoring. In the past few years, direct oral anticoagulants (DOACs) were introduced to circumvent
the frequent monitoring of classical ones, and therefore decrease the burden on public health systems
in countries where the growth of the elderly population has spread the cardiovascular disease impact.
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But there is a need to measure the effectiveness of these treatments, especially near the patient.
The use of biomimetic microfluidic channels for studying the hemostasis process reduces the time and
the number of samples required, and provides a tool to provide results near the patient.
2. Materials and Methods
2.1. Microflow Chamber Design and Manufacturing
The microfluidic device has three main parts: A polydimethylsiloxane (PDMS) part that contains
an open microfluidic channel, and it has been manufactured by conventional lithography methods,
with a glass-cover to mimic the vasculature tissue and a 3D-printed frame, see Figure 1b. The goal of
the printed frame is to apply pressure on the glass in order to seal the channel. Two springs that are
embedded in the frame (Figure 1c) allow the exchange of the glass to morphologically characterize the
thrombi after the tests.
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Figure 1. 3D schematics and the picture of the biomimetic microfluidic channel. (a) the cross-sectional
view of the microfluidic channel. (b) 3D assembly of the different parts of the microfluidic channel.
(c) Real image of the microfluidic channel.
As shown in Figure 1 the microfluidic PDMS part has a channel (width (w = 500 µm), length
(L = 10 mm), depth (d = 50 µm)). Two side channels are made with a 1.5 mm puncher to connect with
the inlet and outlet of the device. Finally, the channel is sealed with the glass, which is previously
coated with collagen and placenta tissue factor to mimic blood vessel structure.
2.2. Biomimetic Coatings and Sample Preparation
Glass sl des (18 mm × 18 mm × 1 mm, from Delta L b) and interdigitated electrodes (Mi rux
ED_IDE3-Au) were cleane and functionalized with collagen and tissue factor. Functionalized slides
or electrodes were stored at 4 ◦C overnight. Once assembled, channels were coated overnight with
collagen Type I (Chronology Corp. Havertown, PA, USA) and tissue factor (I novin, Siemens, Madrid,
Spain) to achieve coating concentrati ns equivalent to 30.9 mg/cm2 and 0.95 ng/cm2, respectively, as
previously described [17], and were flushed with saline prior to perfusion in order to eliminate the
remaining collagen over the surface.
Blood samples were collected from healthy adults (n = 10) after written consent in accordance
with the ethics committee from the Hospital Clinic de Barcelona.
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Blood was drawn into a syringe prefilled with low molecular weight heparin (LMWH) and
centrifuged at 14,000 rpm for 2 min to obtain plasma poor in platelets (PPP) and at 1,000 rpm for 3 min
to obtain plasma rich in platelets (PRP). PPP and PRP will be used to study the formation of fibrin and
platelets aggregates, respectively.
2.3. Flow Assays
The study of blood or plasma flow in a square microchannel can be analyzed by solving the
steady-state Navier-Stokes equation for low Reynolds numbers:
∇ · u = 0. (1)
∇P = ∇ · τ (2)
where u is velocity, P is pressure and τ is the wall shear stress.
The wall shear stress can determine the growth rate of the thrombi during the coagulation
process, and it is one of the parameters under the study [18]. Blood is stored in a collection tube with
anti-coagulants, and then using a centrifuge, the main cells (red blood cells (RBCs) and white blood
cells (WBCs)) are separated from the plasma. Plasma constitutes around 55% of the blood volume,
and contains numerous proteins, including the clotting factors which are the focus of this study,
and other suspended materials. For blood coagulation studies, PRP and PPP are used to evaluate the
function of platelets and fibrin(ogen), respectively. While whole blood behaves as a non-Newtonian
fluid, and the viscosity changes with the applied shear rate, plasma with a water content of almost 95%
behaves as a Newtonian Fluid.
For Newtonian fluids, the shear stress is linearly proportional to the shear rate
.
γ, and the shear
rate tensor can be expressed as τ = η · .γ, being that η is the viscosity of the fluid. Using the relation
between the flow rate Q in a rectangular microchannel and the Pressure loss [19]
Q ≈ wd
3
12ηL
∇P
[
1− 0.63 d
w
]
(3)
where w is the width of the channel, d is the depth and L the length.
Then the wall shear rate
.
γ can be related to the volumetric flow rate Q according to [20]:
.
γ ≈ 32 Q
pi D3h
(4)
where Dh = 2w · d/(w + d) is the hydraulic diameter of the rectangular channel. Since plasma behaves
approximately as a Newtonian fluid, a wall shear rate
.
γ of 300 s−1 was achieved on the glass surface,
applying a flow rate of 0.1 mL/h to the microchannel through a syringe pump.
2.4. Image Capture and Analysis
The perfused channels were fixed with paraformaldehyde 1% for 15 min at 4 ◦C and further
incubated with glycine 1% for 10 min to reduce high background staining due to free unreactive
aldehyde groups. Then the channels were blocked with 1% bovine serum albumin (BSA) for 15 min
prior to incubating with specific antibodies. A combination of indirect and direct immune-fluorescence
was carried out as follows.
First, platelets were stained with a mouse anti-CD36 primary antibody for 1 h at room temperature
(RT, 37 ◦C) in a humidified chamber. Then, a secondary antibody anti-mouse Alexa Fluor 488 was
incubated together with a conjugated antibody anti-fibrinogen Alexa Fluor 594 for 1 h at RT in a
humidified chamber. Pictures were acquired using a confocal microscope (SP5, Leica Microsystems,
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Barcelona, Spain). Acquired images from the channels of the micro-chamber were analyzed using the
ImageJ software (v 1.43m), (Rasband, W.S., ImageJ, National Institutes of Health, Bethesda, MD, USA).
Co-distributions between the platelets (green) and fibrin (red) were analyzed. The intensity of
each marker was densitometrically analyzed individually in each picture, superposed and expressed
as a percentage of the covered surface corresponding to the entire image.
2.5. Impedance Characterization
Electrochemical Impedance Spectroscopy (EIS) studies the system response to a small amplitude
sinusoidal signal at different frequencies, and it can give information about the analytic molecules in a
fluidic solution (for instance, a blood sample). In this new chamber, the glass slide was replaced by the
glass with printed electrodes (ED_IDE3-Au) from Micrux (Oviedo, Spain), see Figure 2.
Micromachines 2019, 10, x 5 of 11 
 
2.5. Impedance Characterization 
Electrochemical Impedance Spectroscopy (EIS) studies the system response to a small amplitude 
sinusoidal signal at different frequencies, and it can give information about the analytic molecules in 
a fluidic solution (for instance, a blood sample). In this new chamber, the glass slide was replaced by 
the glass with printed electrodes (ED_IDE3-Au) from Micrux (Oviedo, Spain), see Figure 2. 
 
Figure 2. (a) Pictures of the test chamber assembled and open. (b) Pictures of the microfluidic channel 
inside the test chamber with the thrombogenic surface with embedded electrodes. (c) Impedance 
model of the electrode inside the channel. 
Figures 2a,b show different images of the biomimetic microfluidic channel for impedance 
measurements. Now the glass cover of the channel has the electrodes (ED_IDE3-Au) from Micrux 
which are 180 gold strips separated 5  µm apart and with 5 µm in width, forming a 3.5 mm circle. The 
electrodes close the channel and are biomimetically covered, as described in Section 2.2. Figure 2c 
portrays the schematics of the electric equivalent circuit of the electrodes. When the plasma with the 
platelets (PRP—plasma rich in platelets) or fibrinogen (PPP—plasma poor in platelets) flows on the 
surface of the electrodes, the sensor can be used to determine the composition of the fluidic solution, 
since their components show a different imaginary and real impedance response at different 
frequencies. For an arbitrary electrode, its impedance (ZE) can be described by different components 
according to [21]: 
Z୉ = (Rୱ + 2Zୢ୪) ብቆ
1
jωC୥ቇብ Z୮ (5) 
where Rs is the resistance of the solution, Zୢ୪ = (Rୡ୲ + Z୵) ∥ ቀ ଵ୨னେౚౢቁ is the double-layer impedance 
and Cg is the dielectric capacitance and Zp the parasitic capacitance of the substrate. 
The resistance of the solution, Rୱ = g (σW)⁄ , relates to the geometry of the electrode g = g(L, S), 
where L is the length of the electrode and S the separation between electrodes and the conductivity 
of the solution σ. In our design, W, the width of the electrode in-plane, and g, are constant parameters 
of the electrode.  
Therefore, Rs is related to the conductivity of the solution, σ = qn୧ (μ୮ + μ୬), where q is the 
electric charge, μ୮ and μ୬ are the ionic mobilities of the dominant positive and negative ions in the 
solution, and n୧ is the ionic concentration, which can vary during coagulation. 
The double-layer impedance (Zୢ୪) captures the phenomena around the electrode; the term Rୡ୲ 
captures the charge transfer between electrodes and Z୵ the mass-transfer between them. In case of 
non-faradaic electrodes, since there is no surface reactions (Rct ⟶ ∞), therefore, there is no mass 
Figure 2. (a) Pictures of the test chamber assembled and open. (b) Pictures of the microfluidic channel
inside the test chamber with the thrombogenic surface with embedded electrodes. (c) Impedance model
of the electrode inside the channel.
Figure 2a,b show different images of the biomimetic microfluidic channel for impedance
measurements. Now the glass cover of the channel has the electrodes (ED_IDE3-Au) from Micrux
which are 180 gold strips separated 5 µm apart and with 5 µm in width, forming a 3.5 mm circle.
The electrodes close the channel and are biomimetically covered, as described in Section 2.2. Figure 2c
portrays the schematics of the electric equivalent circuit of the electrodes. When the plasma with
the platelets (PRP—plasma rich in platelets) or fibrinogen (PPP—plasma poor in platelets) flows
on the surface of the electrodes, the sensor can be used to determine the composition of the fluidic
solution, since their components show a different imaginary and real impedance response at different
frequencies. For an arbitrary electrode, its impedance (ZE) can be described by different components
according to [21]:
ZE = (Rs + 2Zdl)
∣∣∣∣∣∣
∣∣∣∣∣∣
 1jωCg
∣∣∣∣∣∣
∣∣∣∣∣∣Zp (5)
where Rs is the resistance of the solution, Zdl = (Rct + Zw)‖
(
1
jωCdl
)
is the double-layer impedance and
Cg is the dielectric capacitance and Zp the parasitic capacitance of the substrate.
The resistance of the solution, Rs = g/(σW), relates to the geometry of the electrode g = g(L, S),
where L is the length of the electrode and S the separation between electrodes and the conductivity of
the solution σ. In our design, W, the width of the electrode in-plane, and g, are constant parameters of
the electrode.
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Therefore, Rs is related to the conductivity of the solution, σ = qni
(
µp + µn
)
, where q is the
electric charge, µp and µn are the ionic mobilities of the dominant positive and negative ions in the
solution, and ni is the ionic concentration, which can vary during coagulation.
The double-layer impedance (Zdl) captures the phenomena around the electrode; the term Rct
captures the charge transfer between electrodes and Zw the mass-transfer between them. In case
of non-faradaic electrodes, since there is no surface reactions (Rct→∞ ), therefore, there is no mass
transfer. Besides, Zw ≈ 0, Zdl =
(
1
jωCdl
)
, where Cdl originates from the adsorbed charge layer and
diffuse layer charge. For electrode separation higher than Debye length (λ ∼ 1 µm), Cdl can be
described by diffuse layer capacitance Cdl = Cdi f = A
√
2εniq2
kT cosh
( q Vac
2kT
)
, where A is the area of the
electrode (A = wL), Vac is the voltage applied, q is the electric charge, k is the Boltzmann constant, T is
the temperature of the solution, and ε is the permittivity of the medium separating the electrodes.
For a parallel plate system, the geometric capacitance form by the electrodes and the solution is
Cg = A ε/S, where A is the area of the electrodes, ε the permittivity of the medium separating the
electrodes and S is the separation between the electrodes.
If the substrate is highly resistive, such as glass (low dielectric constant), the frequency response
of an ideal non-Faradaic shows three different regions:
1. For low frequencies flow = 22piRsCdl , Cdl dominates the impedance measured.
2. For frequencies flow < f < fhigh = 22piRsCg , Rs is the dominant impedance.
3. For frequencies f > fhigh, Cg is the dominant impedance.
The time dependence of the different components is:
Rs is depending upon the concentration of the ions in the solution, since during coagulation
different ions are involved. Rs will change during the coagulation process; basically, if the concentration
is increased, the conductivity will increase and Rs decreases.
Cdl will also increase if the concentration of ions is increased, and finally, the Cg is independent on
the ion concentration. Cg changes could be related to changes in the permittivity of the solution, that
could change if there were volume changes of the sample, but since our system is inflow, the volume
covering the electrodes is constant.
Therefore, as the blood clot is forming, the change in ion species will be detectable using impedance,
and the combination of this quantification method with the biomimetic microfluidic chamber allows a
quantification of the effects of the shear rate of the process of clot formation.
To study this change of impedance, PalmSens 4 EIS was connected to the electrodes to measure
impedance at different frequencies, see USB connection in Figure 2. A 100 µL PPP or PRP sample is
loaded to an Eppendorf and withdrawn with a syringe pump.
Prior to each test, the plasma (PPP or PRP) was placed at room temperature for 30 min. Then,
the plasma sample was mixed with 1 µL calcium chloride (CaCl2 (5mM)) to induce coagulation.
Electrical impedance across the electrodes between 10 Hz and 1 MHz was measured while a sinusoidal
voltage of 250 mV was applied.
Illustration of the electrodes in contact with the sample and a photograph of the microfluidic chip
is shown in Figure 2.
3. Results
3.1. Flow Assay Results
Figure 3 provides a representative image of the results of microfluidic studies of whole blood with
different doses of APLIX and the generated distribution of platelets and fibrin on the perfused surface.
The right panel shows bar diagrams representing the proportions of platelet aggregates in green and
fibrin masses in red interacting with the collagen/tissue factor surface, as evaluated following the
procedure mentioned in Section 2.4. To evaluate the effects of APIX samples with different APIX doses
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where tested, see Table 1. Bar graphs in the right of Figure 3 quantify the percentages of the total
surface exposed that are covered platelets and fibrin platelet, respectively.Micromachines 2019, 10, x 7 of 11 
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i r 3. Confocal image labeled by immunofluorescence for morphometric analysis from microfluidic
studies. (a) Confocal image showing platelets labeled byanti-CD36 Alexa Fluor 488 and ibrin labele
by anti-fibrin(ogen) Alexa Fluor 594. The thrombogenic surface is a biomimetic combination with
type-I fibrillar collagen (30.9 mg/cm2) and tissue factor (0.95 ng/cm2). Scale bar = 20 µm. (b) The plot
shows the quantification of platelet aggregates (green) and fibrin masses (red) interacting with the
collagen/tissue factor surface. The bar graphs in the right panel summarize the results as percentages
of the total surface exposed.
Incubations with different APIX doses caused dose-dependent decreases in platelet and fibrin
surface, reaching levels of statistical significance at 160 ng/mL (* p < 0.05 vs. control without APIX and
# p < 0.05 vs. APIX 10 ng/mL), see Table 1. Microfluidics studies with recalcified citrated blood show
similar results with conventional methods at the same shear rate. Table 1 summarizes the percentages
of the covered surface.
Table 1. Percentage of the covered surface at shear rate 600 s−1.
[APIX] ng/mL Platelets Fibrin
0 23.0 ± 3.0 43.4 ± 4.8
10 17.9 ± 0.9 42.1 ± 1.9
40 14.0 ± 5.3 23.4 ± 7.7
160 5.4 ± 2.2 *# 14.1 ± 4.9 *#
3.2. I pedance Spectroscopy ssay esults
he i pedance behavior of the clotting process on PRP and PPP that was studie using a 100 µL of
the sample flowing on the coated electrode as follows is differentiated and repeatable. Figure 4 shows
a different trend for both samples PRP and P . Supplementary material shows different repetitions
of the same experiment with other samples and the same be avior. Since PPP creates a complete
coverage on the electrodes, it affects equally the real and imaginary parts of the impedance detected.
PRP contains a high concentration of platelets creating aggregates during coagulation, see Figure 3
(green dots). Therefore, the main change is focalized n the real part of the impedance.
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Figure 4. Real and Imaginary part of Impedance for plasma poor in platelets (PPP) and plasma rich in
platelets (PRP) over time.
During clotting the coating of the electrodes is changed, modifying the permittivity layer between
the electrodes. In the case of PPP, fibrin formation is uniform on the electrodes, and when the coverage
is full, the influence on the solution conductivity changes are reduced. For PRP, the coverage of
electrodes is not uniform, since the thrombus is always located on certain points, therefore the changes
on conductivity are not relevant; consequently, the variations near the electrode cause a noticeable
change on the real part, while the imaginary part slightly changes.
The spectrum shows a general capacitive behavior at low frequencies (Cdl dominates).
The impedance is high at low frequencies and decreases gradually. Around 105 Hz, the impedance
decreases to the behavior of becoming more resistive (Rs dominates). Both samples PPP and PRP show
the same trend, but the impedance of PRP is always higher due to the increased amount of cellular
component which increases the resistivity of the solution, especially when CaCl2 is added. Figure 5
shows a clear effect of the coagulation on the impedance modulus during the coagulation process,
which results in an increase of impedance. This increase is remarkable for low and high frequencies in
PRP samples, while in PPP samples the impedance increases at frequencies higher than 105 Hz.
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4. Discussion
Previous studies proved the importance of studying on hemostasis underflow conditions for
a better understanding of the process, and nowadays microfluidics technology provides a perfect
platform to study this phenomenon. Most of these studies have focused on a global understanding of
whole blood behavior during the coagulation process.
New oral anticoagulants (NOACs) used in patients with more complex treatment cases require
close monitoring and assessment of the cross-reaction with classic Vitamin K antagonists (VKAs).
Hemostasis is a complex process which at least has a double side contribution from platelets and
fibrin(ogen). Conventional evaluation methods use an important amount of reagent and sample,
and they are time-consuming. However, the introduction of microfabrication techniques has allowed
the replica of vein models and biomimetic surfaces to study the complexity of the coagulation process
in biomimetic environments [11,22,23] with a reduced amount of reagents.
These biomimetic approaches still require the use of further biomolecular techniques to quantify
the presence and quantity of thrombi or clots. Therefore, the techniques are not compatible with
near-patient monitoring strategies. Impedance spectroscopy has successfully been applied to monitor
the growth of bacteria colonies in biofilm formation [24–26]. The behavior can be extrapolated to the
PPP effect that creates a complete coverage on the electrodes similar to biofilm growth, and it affects
equally to the real and imaginary part of the impedance detected, as shown in Figure 4.
PRP contains a high concentration of platelets creating aggregates during coagulation, and during
this process the electrolytes in solution change and affect the impedance. Previous studies focusing on
electrolytes on the solution [27,28] show a different behavior on the real and imaginary part of the
impedance, and besides this, a change depending on the concentration of this electrolytes. PRP samples
have shown an important influence of the electrolytes in solution and the attachment of the thrombi at
the same time, showing a completely differentiated behavior to PPP samples.
The differentiated behavior of PPP and PRP would allow the monitoring of responses to antiplatelet
agents present in the samples, while still being able to assess the impact of anticoagulant therapies
on the different elements of hemostasis. As for sample volumes, the proposed devices work with a
reduced 100 µL sample, and the microfluidics and electronics can be miniaturized in a point of care
(POC) system. Besides, the turnaround results are shortened, facilitating a rapid evaluation of the
anticoagulant activity, the identification of specific patient groups, and the guidance of reversal agents
in case of overdose.
The combination of both analyses (PPP and PRP) in a miniaturized POC device with impedance
measurements can evaluate the contribution of platelets and the coagulation mechanism in minute
blood samples at patients´ bedsides.
5. Conclusions
The present study has combined microfluidics with impedance spectroscopy to diagnose
and control coagulation disorders in a biomimetic approach. The proposed device uses a new
micro-manufactured microflow chamber with interchangeable biomimetic surfaces to measure
coagulation. Evaluation of the impact on coagulation in minute samples (100 µL) spiked with a
new oral anticoagulant APIXABAN (APIX) has been performed using this technique and compared to
previous conventional techniques. Both tests show an excellent agreement.
The biomimetic surfaces can be imprinted with gold electrodes, adding the capability to quantify
the presence of platelets aggregates or fibrinogen formation from a reduced amount of sample and
reagents, and also a minimized time for testing.
Different impedance behaviors of plasma poor in platelets (PPP) and plasma rich in platelets
(PRP) has been observed. PPP changes during coagulation are more noticeable at higher frequencies
and modify both real and imaginary parts of the impedance. PRP changes are remarkable even at low
frequencies, but only at the real part of the impedance. This study is the base for a point-of-care device
Micromachines 2019, 10, 534 10 of 11
capable of quantifying in a short time and near the patient the effect of anticoagulant on fibrinogen
formation or platelet aggregation.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-666X/10/8/534/s1,
Figures S1 and S2: Real and Imaginary part of Impedance for different samples of PPP and PRP over the time.
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Abstract 
Micro Electro Mechanical Systems (MEMS) and microfluidic devices have found numerous 
applications in the industrial sector. However, they require a fast, cost-effective and reliable 
manufacturing process in order to compete with the conventional methods. Particularly, at the 
sub-micron scale, the manufacturing od devices are limited by the dimensional complexity. A 
proper bonding and stiction prevention of these sub-micron channels are two of the main 
challenges faced during the fabrication process of low aspect ratio channels. Especially, in case 
of using flexible materials such as polydimethylsiloxane (PDMS). This study presents a direct 
laser microfabrication method of sub-micron channels using an infrared (IR) ultrashort pulse 
(femtoseconds) capable of manufacturing extremely low aspect ratio channels. These 
microchannels are manufactured and tested varying their depth from 0.5 µm to 2 µm and width 
of 15, 20, 25, and 30 µm. The roughness of each pattern was measured by an interferometric 
microscope. Additionally, the static contact angle of each depth was studied to evaluate the 
influence of femtosecond laser fabrication method on the wettability of the glass substrate. 
PDMS, which is a biocompatible polymer, was used to provide a watertight property to the 
sub-micron channels and also to assist the assembly of external microfluidic hose connections. 
A 750nm depth watertight channel was built using this methodology and successfully used as 
a blood plasma separator (BPS).   
The device was able to achieve 100% pure plasma without stiction of the PDMS layer to the 
sub-micron channel within an adequate time. This method provides a novel manufacturing 
approach useful for various applications such as point-of-care devices. 
Keywords: Femtolaser, Biofabrication, Microfluidic, Blood/plasma separation 
 
1. Introduction 
The fast improvement of MEMS and microfluidics during 
the last decade has allowed the development of new research 
areas [1][2]. Currently, this research has consolidated on new 
devices that require cost-effective and reliable manufacturing 
processes. Rapid prototyping is an important stage in the 
fabrication of these systems, enabling fast verification of 
designs without the need for microfluidic simulations that do 
not always prove to be accurate enough [3]. For these 
applications, there are many materials and manufacturing 
methods such as photo sensible resins (SU-8) and polymers 
(PDMS) which are shaped by conventional soft lithography or 
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selective laser sintering printers [4]-[9]. PDMS is one of the 
most used polymers for its excellent optical properties and 
compatibility with different microfluidics and biological 
applications, however, its low Young modulus can produce a 
collapse of the structure at low aspect ratios. Glass is another 
candidate but the hose connections can not be easily 
integrated. For diagnostic applications, there is a need to 
achieve low aspect ratio channels which can be connected 
easily to external pipes. Structuring adequately the surface of 
the glass can allow the combination of both materials for low 
aspect ratio structures and facilitating the fabrication of 
biocompatible applications. 
Blood is classified as connective tissue and is composed of 
two elements: plasma and blood cells. Plasma is essentially an 
aqueous solution and constitutes around 55% of the blood 
volume. Blood cells are Red Blood Cells (RBCs), White 
Blood Cells (WBCs), and platelets. Plasma is the base of a 
wide range of assays and is needed at clinical chemistry testing 
for prognosis [8]. To this end, there is a need for a low cost 
and reliable method to produce blood plasma filters that can 
separate plasma from a single droplet of blood. Previous 
researchers have focused on low aspect ratio channels to 
achieve filtration using wet chemical etching on the glass 
[10][11]. This method is based on extremely aggressive 
chemicals with a huge environmental impact and difficult to 
industrialize. Therefore, there is a manufacturing limitation to 
provide cost-effective and reliable method channels with a 
characteristic height lower than 1.5 µm for blood-plasma 
filtering. RBCs are biconcave, measuring approximately 6 to 
8 µm in diameter and a thickness at the thickest point of 2 to 
2.5 µm and a minimum thickness in the center of 0.8 to 1 µm, 
being much smaller than most other human cells which under 
high shear flows the shape of the red blood cells can deform 
[12] reducing its smaller dimension even to less than 1 µm. 
Consequently, channels with less than one micron in depth are 
required to achieve a reliable filtration rate and also it is 
necessary to avoid high shear stress to prevent cell 
fragmentation. 
There are a large portfolio of manufacturing methods to 
produce channel dimension in micron-scale [13]-[15], 
however, at the sub-micron range, the manufacturing 
processes are more complex [16] and limited, especially if 
watertight channels are required [17]. Focusing on watertight 
channels, Chen et. al [18] presented a fabrication method 
using PDMS that took advantages of simplicity and low cost 
although the material deformed easily. Turning this 
disadvantage into an advantage, Park et.al [19] studied the 
PDMS collapse related to the ratio of width and depth of the 
original micro-channel to form sub-micron channels 
afterward. Reactive Ion Etching (RIE) is a well-known 
manufacturing method capable to manufacture from 40-nm to 
300-µm-depth channels on different base materials such as 
glass [20] or PDMS [21] but limited to cleanroom facilities. 
Laser beam machining (LBM) is a growing non-traditional 
machining process where laser thermal energy is used to 
remove material from metallic or non-metallic surfaces [22]. 
Different laser source wavelengths are used to machine 
infrared (IR) and ultraviolet (UV) wavelengths range. CO2 IR 
lasers are the most widely used and more cost-effective 
compared to UV although when it is used on some polymeric 
materials the temperature of the laser not only reduces the 
precision but also changes the material properties. This 
technology has been used in micron range to produce through 
holes which requires assembly to achieve the whole 
microfluidic device, such as Hao-Bing et al. [23] where the 
channel shape was defined using CO2 laser on a precured film. 
Other authors used Polymethylmethacrylate (PMMA) and 
pressure-sensitive adhesives [3][24][25] but the range of 
channel thickness was always limited to the micron range and 
bonding was more complex, therefore different materials were 
required [24] or different laser passes [26]. From the other 
hand controlling the wettability of the surface is important for 
various practical applications. For instance, hydrophilic 
surfaces are useful for capillary behavior in microfluidic 
channels while hydrophobic surfaces are good for self-
cleaning of contaminations. However, hydrophobic surfaces 
are difficult to bond. As glass substrates are useful for various 
applications, we study the controlled modification of 
characterized surface wettability with femtosecond laser 
passes [25].  
UV laser sources energy concentration is high and can 
generate a smaller focus spot size in sub-micron level, but the 
range of materials is limited.  Matthew et al. [27] used UV 
laser ablation to machine micron-sized channel on 
biocompatible polymers, however further thermal bonding 
was required. IR femtosecond laser technology joints the wide 
range of materials with precision. Nowadays, IR laser sources 
(i.e. ytterbium) with ultrashort pulses opens the possibility to 
achieve high precision. Ultra-short-pulse lasers can machine 
substrates at the wavelength where they are usually 
transparent. This provides a precision down to the tenth of 
nanometers without affecting the nearby area [28]. 
Researchers implemented this technology with a directly fully 
enclosed channel [29] in the micron range, and it is being 
introduced in the industry to drill high-aspect-ratio holes. 
This manuscript presents a laser direct microfabrication 
method that uses IR femtosecond laser pulses to produce anti-
stiction [30] extremely low aspect ratio sub-micron channels 
on a glass substrate. At atmospheric conditions, different 
channel depths has been manufactured from 500 nm to 2µm. 
The sub-micron channel is sealed by a PDMS layer via 
Oxygen-plasma to enable the watertight behavior without the 
need of any other step or layer. 
A BPS is manufactured by this method to filter the cellular 
component of blood and achieves 100% pure plasma from 
undiluted blood. This method improves the reproducibility on 
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the size and the shape from the method presented by Park et.al  
[19] which is faster and easier than RIE [20][21]. Importantly, 
the stiction of the PDMS layer either during the manufacturing 
process or during the operation [27] is avoided due to the 
texture and roughness of the laser machined surface of the 
glass. To confirm if surface wettability is a function of surface 
morphology, surface roughness is measured and the regime is 
studied between two well-known wetting theories by Wenzel 
[31] and Cassi-Baxter [32]. 
2. Materials and method 
Firstly the potential of femtosecond laser micromachine for 
rapid prototyping of microfluidic channels on the surface of 
glass substrates was assessed. To validate the femtosecond 
laser manufacturing accuracy in the sub-micron range, a 
template with different channels was designed. Each channel 
was formed by two parallel rectangular blocks to investigate 
the in-plane accuracy. The distance between the two blocks 
(channel width) is the same as the width of the block. Different 
channel depth was studied, modified H parameter from 500 
nm to 2 µm as shown in Figure 1. This figure shows the details 
of dimension W that characterizes these columns which vary 
from 15 µm to 30 µm. These rectangular cross-section 
microchannels were fabricated by performing different laser 
passes for each depth with the same laser power. 
After studying the influence of different patterns and different 
height on the glass, the desired sketch was carved to develop 
a blood plasma filtering device. This pattern is a reservoir with 
an array of pillars which not only holds the weight of PDMS 
on the top but also conduct the extracted plasma in the 
reservoir to the plasma collector channels as it is shown in 
Figure 2. 
To manufacture the desired shape and depth on the glass, the 
femtosecond laser works as an engraving machine using a 
laser spot of approximately 10 µm, with the power of 20W, 
and pulse duration of approximately 350fs. The femtoseconds 
laser is controlled by a CNC system and depending on the 
depth different passes are required on the surface. Each laser 
pass is 120º tilt from its previous to ensure the maximum 
uniformity at the engraving area. First laser pass made 0.5-
µm-depth and after that for each laser pass, 0.25-µm-depth is 
used. Therefore, for the channel of 2 µm depth, the laser 
performs 7 passes. 
Surface roughness has a strong effect on wettability of a 
surface and the contact angle. The effect of roughness changes 
if the droplet wets the surface grooves or if air pockets are left 
between the droplet and the surface. Two different theories 
were developed to explain the effect of surface roughness on 
wettability. If the surface is wetted homogeneously, the 
droplet is in Wenzel [31] state. In Wenzel state, adding surface 
roughness will enhance the wettability caused by the 
chemistry of the surface. This model predicts enhanced 
hydrophilicity for hydrophilic surfaces and an enhanced 
hydrophobicity for hydrophobic surfaces. This model takes 
into account a complete wetting of droplet with the underneath 
substrate. If the surface is wetted heterogeneously, the droplet 
is in Cassie-Baxter [32] state. This model assumes that the 
liquid does not completely wet the roughened substrate. The 
Cassie-Baxter model predicts that roughening a surface 
always increases the contact angle. If a surface is rough 
enough so that air may be entrapped between the liquid and 
the solid, the interface becomes composite and the contact 
angle increases with roughness even if the surface chemistry 
is intrinsically hydrophilic. The most stable contact angle can 
be connected to the Young contact angle. The contact angles 
calculated from the Wenzel and Cassie-Baxter equations are 
Figure 2: (a) Schematic of the BPS device which contains a 
PDMS block on the top part and an engraved glass by laser on 
the bottom part. (b) a picture of the real device. (c) The pattern 
that is carved on the glass with the dimensions of the array of 
diamond pillars. 
Figure 1: (a) 2D view of the seven different Template in 
depth (H) from the range of 0.5µm (Nanochannels) to 
2µm (microchannels). Each template fabricated in four 
different channel width (w): 15µm, 20 µm, 25 µm, and 
30 µm. (b) the 3-D view schematic of one template. (c) 
the top view of the template. 
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good approximations of the most stable contact angles with 
real surfaces. 
The obtained nano and microchannels were measured using a 
confocal microscope model Sensofar PLU neox with a 10XDI 
objective to evaluate the accuracy on the sub-micron range 
depth. Furthermore, the surface roughness was evaluated 
using an optical zoom 4X in an area of 317.06 x 237.38 µm2. 
The channel template of Figure 1a was manufactured three 
times. This template contains four different width columns (15 
µm, 20 µm, 25 µm, and 30 µm) that form a channel between 
them with the same dimension, see drawing dimension W at 
the detail of Figure 1. 
In order to investigate the influence of the roughness 
generated by the femtosecond laser irradiation on surface 
wettability, the measurement of the static contact angle of each 
template was carried out using an optical video contact angle 
system (OCA software, SCA20 module, Dataphysics). To 
perform the test, a 0.7 µL droplet of de-ionized water 25º, 
having a surface tension of 71.99±0.05 mN/m, was dispensed 
on the samples using a 500-µL Hamilton syringe unit. The 
static contact angle based on the Young-Laplace fitting was 
measured using the sessile drop method with dedicated 
software.  
2.1. Device Fabrication 
The device is conceived in two parts: A PDMS layer where 
the microchannels and the external connection are located in a 
glass holder that has the sub-micron reservoir pattern. Figure 
3 shows the three steps of the manufacturing process. Step A 
includes a conventional soft lithography process to make a 
mold. The pattern of the microchannels on the PDMS is 
engraved by this mold. Besides, the syringe pump is connected 
through the external connection on the PDMS. Step B uses 
femtoseconds laser pulses to define the low-aspect-ratio pillar 
shapes and the sub-micron channel walls on the glass. for this 
manner firstly, a 2D model of the sub-micron channel was 
defined using AutoCAD 2018 as shown in Figure 2c. The 
model with Rhinoceros was edited to define the regions to 
manufacture the micro-channel of a certain depth. A 
Figure 3: Manufacturing method steps. A is the manufacturing method of the micro-channels on a PDMS base. B is the nanochannels 
manufacturing method on a glass base. C is the bonding process that has a watertight channel. 
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femtosecond laser model AgieCharmilles LASER P 400 U 
was used. The sub microchannel was cleaned using sonication 
and immersion in a Piranha solution as following: 
First: sonication using acetone for 15min and rinsing with 
distilled water. 
Second: 20min in Piranha (1:3 H2O2:H2SO4) and rinsing 
with distilled water and dry on the hot plate at 95ºC for 10 
minutes right before the PDMS-Glass bonding process starts. 
In step C the PDMS is bonded to the glass via Oxygen plasma. 
In order to ensue the hose connections are sealed completely, 
Norland Optical Adhesive 63 (NOA63) is used. This adhesive 
is a clear, colorless, liquid photopolymer that will cure via UV 
light exposure. 
2.2. Blood plasma separator (BPS) 
In order to validate the fabricated sub-micron pillars, a BPS 
system was designed and manufactured as an application. The 
BPS contains two parts; the bottom part is a glass which 
carved by laser in depth of 0.75 µm and contains an array of 
diamond pillars in order to hold the weight of the top part 
which is a PDMS block. The PDMS has three separated 
channels, one main channel in the middle of two lateral 
channels. The main channel is filled by the blood sample and 
two collector channels are designed to collect the extracted 
plasma by capillary force. The PDMS and the glass were 
bonded via Oxygen plasma. The PBS device was placed under 
an optical upright microscope (Dino-Lite Digital Microscope 
Edge Series USB Cameras). 
The blood samples that are used in the BPS were collected 
from healthy volunteers from Banc de Sang i Teixits de 
Catalunya.. The samples were stored in a vacutainer collection 
tube which contains anti-coagulant (Ethylenediamine tetra-
acetic acid) to postpone the coagulation phenomena during the 
experimental setup. To maximize the livability of the cellular 
components, the samples were stored at 4 ºC temperature and 
were gently mixed back and forward to prevent possible 
undesirable cell sedimentation prior to testing. All the 
experiments were processed at the room temperature (20-25 
°C). 
The blood sample was injected from the blood inlet using a 
syringe pump at a flow rate of 10 ml/min. The height of the 
pillars is 0.75 µm to prevent entrance of red blood cells at the 
plasma collector channel even at high shear forces. Then pure 
plasma was driven to the plasma reservoir and blood with a 
higher concentration of red blood cells was drawn from blood 
outlet.  
To evaluate the quality of the plasma and the performance of 
the sub-micron filter, the plasma purity parameter was 
measured. An image processing was developed by an open-
source ImageJ software to analyze the particles by their 
population. To determine the purity of the extracted plasma, a 
rectangular area (200 µm × 400 µm) in the blood inlet was 
selected and compared with the same size area in the plasma 
outlet. These areas were captured by microscope after the 
plasma collector channels were filled completely. The number 
of blood cells in these areas were counted by the particle 
analysis method of the ImageJ software. The plasma purity 
evaluates the number of red blood cells ratio at the plasma 
outlets compared to the initial red blood cells at the inlet 
according to equation 1.  
𝑃𝑢𝑟𝑖𝑡𝑦% = (1 − (
𝑓𝑖𝑛𝑎𝑙 𝑐𝑒𝑙𝑙𝑠 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑒𝑙𝑙𝑠 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
)) ∗ 100%                 (1) 
 
3. Results & discussion 
3.1. Sub-micron channels manufacturing method 
During the manufacturing process, the laser is focused on the 
material surface that absorbs the energy and transforms it into 
the gaseous state to generate the sub-micron channel. For 
extremely low depth 0.5 µm, the ablation of the surface may 
not be complete and, according to Figure 4a, some protruding 
peaks appear. Figure 4b shows a cross-section of the 
manufactured part and in this figure. For 0.5- µm –depth 
channels, the material ablation is not completed or some 
ablated material is deposited and bonded again at the surface 
forming some protruding peaks. These peaks avoid the 
achievement of a flat surface and prevent a complete seal with 
the PDMS cover. Figure 4 clearly shows the pattern of the 
Figure 4: 0.25-µm-width and 0.-5µm-depth channel template 
measurement using a confocal microscope. (a) shows the 3D 
view of the region treated with the laser that contains some 
protruding regions. Redline is the cross-section position is 
shown in (b). The cross-section shows the protruding regions 
are higher in depth than the level of the original surface. 
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laser machining direction for 0.5-µm-depth channels while in 
0.75-µm-depth channels template this pattern disappears as 
shown in Figure 5. This is due to the fact that two laser passes 
were performed to define the depth. Furthermore, the 
protruding peaks disappear as well, see Figure 5 and more 
roughness is generated on the surface. 
Figure 6 shows that there is no influence of the channel width 
on the roughness and outlines that the roughness increases as 
the depth of the channel increases, which means the number 
of laser passes increases. Additionally, when the number of 
laser passes is an odd number (the case of 1-µm, 1.5-µm, and 
2-µm-depth template) the roughness presents a maximum and 
at even number (the case of 0.75-µm, 1.25-µm, 1.75-µm depth 
template) the roughness improves. This is due to the second 
laser pass which improves the roughness that the previous 
laser pass pattern. 
As shown in Figure 7, the width of the channel has higher 
accuracy when the channel width and depth are lower. Results 
also denote that channel depth has a higher influence on 
accuracy. For channels with less than 1µm-depth, the 
deviation is between 0.4% and the deviation reaches 7% when 
the channel width increases. The accuracy regarding the depth 
increases with it reaching a maximum of 10% deviation for 
the 2 µm-depth channels. As it is mentioned before, to achieve 
higher depth, the number of laser passes increases. This fact 
has a certain effect on the distance between the columns 
defined. This distance increases 550 nm ± 100 nm at each laser 
pass from the designed dimensions. This accuracy is one order 
of magnitude higher than in conventional soft lithography. 
However, the depth of the channels is unachievable by soft 
lithography. On the other hand, when the channel depth 
increases, the channel width increases as well, therefore, 
lowering the precision, but being still similar to the soft 
lithography process. For wider channels, the accuracy of the 
laser decreases exponentially as shown in Figure 8. This figure 
shows the case of the template of 30 µm width and 0.75 µm-
depth, where the deviation is 1.54 µm and this deviation 
increases with the depth reaching a 4.31 µm deviation for the 
template of 2 µm-depth. As it is expected, the width of the 
column has the opposite behavior, as the depth of the channel 
increases the column becomes narrower and the channel width 
Figure 5: Channel template of 0.75 µm depth and 15µm width 
measurement using a confocal microscope 
Figure 6: Confocal surface roughness (Sa) measurements 
from 0.75 µm to 2 µm depth channel template with a different 
width. It expresses, as an absolute value, the difference in 
height of each point compared to the arithmetical mean of the 
surface. N is the number of laser passes. 
Figure 7: Confocal 3D measurement of the channel width and the column width at the channel template depth 0.75 µm, 
1 µm, 1.25 µm, 1.5 µm, 1.75 µm, and 2 µm. 
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increases. When the channel depth is low, the width of the 
column is in an average of a 10% wider than the designed 
dimensions and as the channel depth increases this tendency 
decrease; for the case of 2 µm-depth channels, the width of the 
column is in an average of a 3.6% narrower than the designed 
dimensions. 
The angle of contact between pure water and a perfectly clean 
glass is 0°and  for ordinary water increase from 8° to 18°. 
Figure 9a shows the static contact angle on glass samples 
irradiated at laser pass of 2, 3, 4, 5, 6, and 7, revealing a 
hydrophilic behavior for all the different laser passes but show 
a dependence of the wettability on the laser passes employed. 
As shown in Figure 9b the measured contact angle is 11°, since 
dionized water is used on a slide of glass. 
This actual behavior can be explained assuming that the 
texture generated during the laser machining, trap air between 
the water and the glass substrate below, preventing a complete 
wetting of the substrate. Interferometry images of Figure 4a 
and Figure 5a show the cross-section of the profile shape, 
characterized by laser groove and peaks. The dimension of the 
grooves does not appear to change significantly, confirming 
that the contact angle measurements depend mostly on surface 
texture rather than the roughness. 
According to the contact angles measurements as shown in 
Figure 9 on the sub-micron range, the channel is completely 
hydrophilic to perform self-driven fluid test [10] and useful 
for the blood plasma separator applications. 
3.2. Blood plasma separator Application 
Figure 10 shows the schematic of the top view of the BPS 
device and also the microscopic picture of the channels. Blood 
was injected from the inlet and flew through the main channel 
as shown in Figure 10. Afterward, the plasma was spread 
through the bottom part. Since the height of the pillars was less 
than the minimum size of RBCs, all the cells were trapped in 
the main channel. The pure plasma in the bottom part was 
Figure 10: The schematic of BPS device from the top view 
and the microscopic view of the BPS right after the blood 
injection. 
Figure 9: (a)Contact angles measurements at the template depth of 0.5 µm,  0.75 µm, 1 µm, 1.25 µm, 1.5 µm, 1.75 
µm, 2 µm. Zero is on the surface of the glass. (b)Microscopic picture of the contact angle measurement of a 0.7 µl 
of DI water on the glass template depth of 0 µm. 
 
a)  b) 
n = 1 
n = 7 
n = 3 
n = 5 
n = 2 
n = 6 
n = 4 
Figure 8: Channel width standard deviation at depth of 0.75, 
1, 1.25, 1.5, 1.75, and 2 µm. 
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filled in two lateral channels by the capillary. Figure 10 also 
shows the filling process of plasma into the lateral channels. 
After directly counting the number of blood cells in blood inlet 
and plasma outlets, by the help of ImageJ software, it has been 
confirmed that final blood cells in the plasma collector 
channels were zero. Since no cell could penetrate to the lateral 
channel, the purity of the extracted plasma according to 
equation 1 was obtained 100%. The excellent purity of the 
extracted plasma is the significant advantage of this BPS. This 
figure also denotes the high transparency of the BPS that 
allows analyzing the calorimetry and particle counting. 
 
4. Conclusion  
A novel method to manufacture a watertight sub-micron 
channel has been developed and tested. The open-top sub-
micron channels with an array of pillars were manufactured 
using a femtosecond laser and the watertight property was 
reached by a PDMS cover. The femtosecond laser has been 
evaluated to manufacture sub-micron channels above 500nm. 
The applicability of the manufactured sub-micron channels 
have been validated in a BPS device. Plasma was successfully 
extracted from blood with the highest efficiency of 100%. This 
method has several advantages compared to current sub-
micron watertight manufacturing methods: 
 It is a rapid manufacturing method for channel dimension 
greater than 750 nm in depth. (about 40 seconds for a 
rectangles with the area of 18.5*12.5 mm2) 
 The PDMS is not sticking to the sub-micron channel 
either during the bonding fabrication or operating the 
device due to the texture of the surface.  
 The number of laser passes has a significant influence on 
the pattern. The odd number of laser pass increases the 
roughness while the next laser pass decreases the 
roughness. 
 The number of laser passes has an influence on the 
contact angles: as the laser passes increase, the surface 
wettability decreases. 
 The channel width precision decreases when increasing 
the channel width and depth. 
 Laser focus spot size limits the decrease of the width of 
the sub-micron channel. 
 The glass maintains good transparency and enables 
colorimetric and particle counts analysis systems. 
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